[
  {
    "Column": "record",
    "Description": "record: Record number",
    "Answer_Options": "NA"
  },
  {
    "Column": "uuid",
    "Description": "uuid: Participant identifier",
    "Answer_Options": "NA"
  },
  {
    "Column": "date",
    "Description": "date: Completion time and date",
    "Answer_Options": "NA"
  },
  {
    "Column": "status",
    "Description": "status: Participant status",
    "Answer_Options": "1=Terminated,2=Overquota,3=Qualified,4=Partial"
  },
  {
    "Column": "AEr1",
    "Description": "AEr1: Thank you for your interest in our survey. This survey will take, on average, approximately 15 minutes to complete and your answers are confidential. We ask that you answer each question frankly and to the best of your ability. All results are repo",
    "Answer_Options": "0=NO TO:,1=",
    "ParentQuestion": "AE"
  },
  {
    "Column": "S0",
    "Description": "S0: Are you or anyone in your immediate family affiliated in any way with any of the following on a full time or part time basis: the FDA, a pharmaceutical or biotech manufacturing company (other than for clinical trials), a market research, public relati",
    "Answer_Options": "1=Yes,2=No"
  },
  {
    "Column": "S1",
    "Description": "S1: In what state is your primary practice setting/organization located?",
    "Answer_Options": "1=Alaska,2=Alabama,3=Arkansas,4=Arizona,5=California,6=Colorado,7=Connecticut,8=District of Columbia,9=Delaware,10=Florida,11=Georgia,12=Hawaii,13=Iowa,14=Idaho,15=Illinois,16=Indiana,17=Kansas,18=Kentucky,19=Louisiana,20=Massachusetts,21=Maryland,22=Maine,23=Michigan,24=Minnesota,25=Missouri,26=Mississippi,27=Montana,28=North Carolina,29=North Dakota,30=Nebraska,31=New Hampshire,32=New Jersey,33=New Mexico,34=Nevada,35=New York,36=Ohio,37=Oklahoma,38=Oregon,39=Pennsylvania,40=Rhode Island,41=South Carolina,42=South Dakota,43=Tennessee,44=Texas,45=Utah,46=Virginia,47=Vermont,48=Washington,49=Wisconsin,50=West Virginia,51=Wyoming"
  },
  {
    "Column": "hS1",
    "Description": "hS1: Geographic divisions",
    "Answer_Options": "1=New England,2=Middle Atlantic,3=East North Central,4=West North Central,5=South Atlantic,6=East South Central,7=West South Central,8=Mountain,9=Pacific"
  },
  {
    "Column": "hS1_2",
    "Description": "hS1_2: Geographic regions",
    "Answer_Options": "1=Northeast,2=South,3=Midwest,4=West"
  },
  {
    "Column": "S2",
    "Description": "S2: Please select the title/role that best describes your current position within your practice/organization.",
    "Answer_Options": "1=Physician,2=Nurse,3=Nurse Practitioner,4=Physician Assistant,5=Medical Assistant,6=Pharmacist,7=Practice Administrator,8=Practice Manager,9=Financial Counselor or Social Worker,10=Reimbursement Support Role,11=Receptionist, Administrative Assistant or other Administrative Role,12=Other (please specify):"
  },
  {
    "Column": "S2r12oe",
    "Description": "S2r12oe: Please select the title/role that best describes your current position within your practice/organization. - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "S2",
    "Context": "S2: S2: Please select the title/role that best describes your current position within your practice/organization."
  },
  {
    "Column": "hS2",
    "Description": "hS2: Hidden in live",
    "Answer_Options": "1=MD,2=AHP” (ALLIED HEALTH PROFESSIONALS)"
  },
  {
    "Column": "S3",
    "Description": "S3: Which of the following best describes your primary medical specialty?",
    "Answer_Options": "1=Hematology,2=Hematology and Oncology,3=Radiation Oncology,4=Urology,5=Urological Oncology,6=Cardiology,7=Medical Oncology,8=Primary Care, Internal Medicine, General Practice or Family Practice,9=Other (please specify):"
  },
  {
    "Column": "S3r9oe",
    "Description": "S3r9oe: Which of the following best describes your primary medical specialty? - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "S3",
    "Context": "S3: S3: Which of the following best describes your primary medical specialty?"
  },
  {
    "Column": "S3a",
    "Description": "S3a: Which specialty do you most closely identify yourself with?",
    "Answer_Options": "1=Oncologist,2=Urologist"
  },
  {
    "Column": "hS3a",
    "Description": "hS3a: Hidden in live",
    "Answer_Options": "1=ONC,2=URO"
  },
  {
    "Column": "S1a",
    "Description": "S1a: Which of the following best describes your primary practice setting/organization? Please check the description that best applies to the practice location at which you spend the greatest amount of time.",
    "Answer_Options": "1=Major academic medical center,2=Affiliated teaching hospital,3=Community hospital (not affiliated with an academic medical center),4=Community hospital (affiliated with an academic medical center),5=Multi-specialty private practice (group),6=Single-specialty private practice (group),7=Private practice (solo),8=VA / Military hospital / DoD,9=Nursing homes,10=Other (please specify):"
  },
  {
    "Column": "S1ar10oe",
    "Description": "S1ar10oe: Which of the following best describes your primary practice setting/organization? Please check the description that best applies to the practice location at which you spend the greatest amount of time. - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "S1a",
    "Context": "S1a: S1a: Which of the following best describes your primary practice setting/organization? Please check the description that best applies to the practice location at which you spend the greatest amount of time."
  },
  {
    "Column": "S4",
    "Description": "S4: Are you currently board-certified or board-eligible in your specialty?",
    "Answer_Options": "1=Board-certified,2=Board-eligible,3=Neither"
  },
  {
    "Column": "S5",
    "Description": "S5: For how many years have you practiced in this specialty, post-residency?",
    "Answer_Options": "NA"
  },
  {
    "Column": "S6",
    "Description": "S6: What percentage of your professional time is devoted to direct patient care / clinical practice as opposed to teaching, research or administration?",
    "Answer_Options": "NA"
  },
  {
    "Column": "S7b_H",
    "Description": "S7b_H: Is your practice a member of Large Urology Group Practice Association (LUGPA)?",
    "Answer_Options": "1=Yes,2=No"
  },
  {
    "Column": "S7a_Hr1c1",
    "Description": "S7a_Hr1c1: Acute myeloid leukemia (AML) - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once in the",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr2c1",
    "Description": "S7a_Hr2c1: Acute lymphoblastic leukemia (ALL) - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once i",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr3c1",
    "Description": "S7a_Hr3c1: Prostate cancer - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 month",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr4c1",
    "Description": "S7a_Hr4c1: Multiple myeloma - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 mont",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr5c1",
    "Description": "S7a_Hr5c1: Chronic lymphocytic leukemia (CLL) - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once i",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr6c1",
    "Description": "S7a_Hr6c1: Bladder cancer - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 months",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr7c1",
    "Description": "S7a_Hr7c1: Breast cancer - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 months",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Hr8c1",
    "Description": "S7a_Hr8c1: Colorectal cancer - In the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 mon",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_H"
  },
  {
    "Column": "S7a_Ur1c1",
    "Description": "S7a_Ur1c1: Prostate cancer - In the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 months",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_U"
  },
  {
    "Column": "S7a_Ur2c1",
    "Description": "S7a_Ur2c1: Bladder cancer - In the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 months f",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_U"
  },
  {
    "Column": "S7a_Ur3c1",
    "Description": "S7a_Ur3c1: Testicular cancer - In the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 month",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_U"
  },
  {
    "Column": "S7a_Ur4c1",
    "Description": "S7a_Ur4c1: Kidney cancer - In the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once in the past 12 months fo",
    "Answer_Options": "NA",
    "ParentQuestion": "S7a_U"
  },
  {
    "Column": "S7_B",
    "Description": "S7_B: Of your [pipe:hS7_B] prostate cancer patients, how many were actively managed for non-curative prostate cancer in the past 12 months? Non-curative prostate cancer patients are those that have progressed after receiving definitive therapy (e.g., radi",
    "Answer_Options": "NA"
  },
  {
    "Column": "S7_C",
    "Description": "S7_C: Of your [pipe:hS7_C] bladder cancer patients actively managed in the past 12 months, how many were locally advanced or metastatic? Include patients you treat currently AND patients you referred to clinical trial in the last 12 months AND your patien",
    "Answer_Options": "NA"
  },
  {
    "Column": "hS7_CTreaterr1",
    "Description": "hS7_CTreaterr1: AML TREATER - hS7_CTreater",
    "Answer_Options": "0=NO TO: AML TREATER,1=AML TREATER",
    "ParentQuestion": "hS7_CTreater"
  },
  {
    "Column": "hS7_CTreaterr2",
    "Description": "hS7_CTreaterr2: BLADDER CANCER TREATER - hS7_CTreater",
    "Answer_Options": "0=NO TO: BLADDER CANCER TREATER,1=BLADDER CANCER TREATER",
    "ParentQuestion": "hS7_CTreater"
  },
  {
    "Column": "hS7_CTreaterr3",
    "Description": "hS7_CTreaterr3: PROSTATE CANCER TREATER - hS7_CTreater",
    "Answer_Options": "0=NO TO: PROSTATE CANCER TREATER,1=PROSTATE CANCER TREATER",
    "ParentQuestion": "hS7_CTreater"
  },
  {
    "Column": "S9r1c1",
    "Description": "S9r1c1: Primary Care, Internal Medicine, General Practice or Family Practice - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your p",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r2c1",
    "Description": "S9r2c1: Hematologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r3c1",
    "Description": "S9r3c1: Hematologist-Oncologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r4c1",
    "Description": "S9r4c1: Medical Oncologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r5c1",
    "Description": "S9r5c1: Gastroenterologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r6c1",
    "Description": "S9r6c1: Urologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r7c1",
    "Description": "S9r7c1: Radiation Oncologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r8c1",
    "Description": "S9r8c1: Urological Oncologist - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r9c1",
    "Description": "S9r9c1: Other (please specify): - Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location.",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9r9oe",
    "Description": "S9r9oe: Approximately, how many physicians of each of the following specialties are currently on staff in your practice? If your practice has multiple locations, please consider your primary location. - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "S9"
  },
  {
    "Column": "S9ar1",
    "Description": "S9ar1: Primary Care, Internal Medicine, General Practice or Family Practice - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Primary Care, Internal Medicine, General Practice or Family Practice,1=Primary Care, Internal Medicine, General Practice or Family Practice",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar2",
    "Description": "S9ar2: Hematology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Hematology,1=Hematology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar3",
    "Description": "S9ar3: Hematology-Oncology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Hematology-Oncology,1=Hematology-Oncology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar4",
    "Description": "S9ar4: Medical Oncology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Medical Oncology,1=Medical Oncology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar5",
    "Description": "S9ar5: Gastroenterology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Gastroenterology,1=Gastroenterology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar6",
    "Description": "S9ar6: Urology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Urology,1=Urology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar7",
    "Description": "S9ar7: Radiation Oncology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Radiation Oncology,1=Radiation Oncology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar8",
    "Description": "S9ar8: Urological Oncology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Urological Oncology,1=Urological Oncology",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "S9ar9",
    "Description": "S9ar9: $ {S9.r9.open} - What is the primary medical specialty of the physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: $ {S9.r9.open},1=$ {S9.r9.open}",
    "ParentQuestion": "S9a"
  },
  {
    "Column": "hS9ar1",
    "Description": "hS9ar1: S9a=3 or 4 CODE AS \"ONC AHP\" - hS9a",
    "Answer_Options": "0=NO TO: S9a=3 or 4 CODE AS \"ONC AHP\",1=S9a=3 or 4 CODE AS \"ONC AHP\"",
    "ParentQuestion": "hS9a"
  },
  {
    "Column": "hS9ar2",
    "Description": "hS9ar2: S9a=6 CODE AS \"URO AHP\" - hS9a",
    "Answer_Options": "0=NO TO: S9a=6 CODE AS \"URO AHP\",1=S9a=6 CODE AS \"URO AHP\"",
    "ParentQuestion": "hS9a"
  },
  {
    "Column": "S10r1",
    "Description": "S10r1: Acute myeloid leukemia (AML) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Acute myeloid leukemia (AML),1=Acute myeloid leukemia (AML)",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r2",
    "Description": "S10r2: Prostate cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Prostate cancer,1=Prostate cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r3",
    "Description": "S10r3: Acute lymphoblastic leukemia (ALL) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Acute lymphoblastic leukemia (ALL),1=Acute lymphoblastic leukemia (ALL)",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r4",
    "Description": "S10r4: Breast cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Breast cancer,1=Breast cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r5",
    "Description": "S10r5: Colorectal cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Colorectal cancer,1=Colorectal cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r6",
    "Description": "S10r6: Multiple myeloma - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Multiple myeloma,1=Multiple myeloma",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r7",
    "Description": "S10r7: Chronic lymphocytic leukemia (CLL) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Chronic lymphocytic leukemia (CLL),1=Chronic lymphocytic leukemia (CLL)",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r8",
    "Description": "S10r8: Bladder cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Bladder cancer,1=Bladder cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r9",
    "Description": "S10r9: Testicular cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Testicular cancer,1=Testicular cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r10",
    "Description": "S10r10: Kidney cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Kidney cancer,1=Kidney cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r11",
    "Description": "S10r11: Other (please specify): - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: Other (please specify):,1=Other (please specify):",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r12",
    "Description": "S10r12: None, physicians I work with directly do not commonly treat cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
    "Answer_Options": "0=NO TO: None, physicians I work with directly do not commonly treat cancer,1=None, physicians I work with directly do not commonly treat cancer",
    "ParentQuestion": "S10"
  },
  {
    "Column": "S10r11oe",
    "Description": "S10r11oe: Which types of cancer are commonly treated by physicians with whom you yourself work directly? - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "S10"
  },
  {
    "Column": "hS10Treaterr1",
    "Description": "hS10Treaterr1: S10=1 CODE AS \"AML AHP\" - hS10Treater",
    "Answer_Options": "0=NO TO: S10=1 CODE AS \"AML AHP\",1=S10=1 CODE AS \"AML AHP\"",
    "ParentQuestion": "hS10Treater"
  },
  {
    "Column": "hS10Treaterr2",
    "Description": "hS10Treaterr2: S10=8 CODE AS \"BLADDER CANCER AHP\" - hS10Treater",
    "Answer_Options": "0=NO TO: S10=8 CODE AS \"BLADDER CANCER AHP\",1=S10=8 CODE AS \"BLADDER CANCER AHP\"",
    "ParentQuestion": "hS10Treater"
  },
  {
    "Column": "hS10Treaterr3",
    "Description": "hS10Treaterr3: S10=2 CODE AS \"PROSTATE CANCER AHP\" - hS10Treater",
    "Answer_Options": "0=NO TO: S10=2 CODE AS \"PROSTATE CANCER AHP\",1=S10=2 CODE AS \"PROSTATE CANCER AHP\"",
    "ParentQuestion": "hS10Treater"
  },
  {
    "Column": "S11r1",
    "Description": "S11r1: Manage initiation kits/bridge programs (free drug for new starts while benefits are being verified or getting approval for coverage) - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer dru",
    "Answer_Options": "0=NO TO: Manage initiation kits/bridge programs (free drug for new starts while benefits are being verified or getting app,1=Manage initiation kits/bridge programs (free drug for new starts while benefits are being verified or getting approval f",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r2",
    "Description": "S11r2: Enroll patients in patient assistance/free drug programs - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Enroll patients in patient assistance/free drug programs,1=Enroll patients in patient assistance/free drug programs",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r3",
    "Description": "S11r3: Coordinate with specialty pharmacies to get patients access to medications - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Coordinate with specialty pharmacies to get patients access to medications,1=Coordinate with specialty pharmacies to get patients access to medications",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r4",
    "Description": "S11r4: Call manufacturer-sponsored reimbursement assistance hotlines - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Call manufacturer-sponsored reimbursement assistance hotlines,1=Call manufacturer-sponsored reimbursement assistance hotlines",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r5",
    "Description": "S11r5: Analyze and work with patients on coverage verification and patient out-of-pocket responsibility amounts - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Analyze and work with patients on coverage verification and patient out-of-pocket responsibility amounts,1=Analyze and work with patients on coverage verification and patient out-of-pocket responsibility amounts",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r6",
    "Description": "S11r6: Work with drug companies to negotiate contracts and/or billing terms - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Work with drug companies to negotiate contracts and/or billing terms,1=Work with drug companies to negotiate contracts and/or billing terms",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r7",
    "Description": "S11r7: Coordinate with drug companies to ensure supplies of samples, address issues with expired drugs, etc. - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Coordinate with drug companies to ensure supplies of samples, address issues with expired drugs, etc.,1=Coordinate with drug companies to ensure supplies of samples, address issues with expired drugs, etc.",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r8",
    "Description": "S11r8: Work with physicians and insurance companies to obtain prior authorizations - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: Work with physicians and insurance companies to obtain prior authorizations,1=Work with physicians and insurance companies to obtain prior authorizations",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S11r9",
    "Description": "S11r9: I do not routinely perform any of the tasks above - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
    "Answer_Options": "0=NO TO: I do not routinely perform any of the tasks above,1=I do not routinely perform any of the tasks above",
    "ParentQuestion": "S11"
  },
  {
    "Column": "S12r1",
    "Description": "S12r1: Astellas - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation a",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r2",
    "Description": "S12r2: EMD Serono - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r3",
    "Description": "S12r3: Bristol-Myers Squibb (BMS) - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussi",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r4",
    "Description": "S12r4: Genentech - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r5",
    "Description": "S12r5: Pfizer - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r6",
    "Description": "S12r6: Janssen / Johnson & Johnson - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discuss",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r7",
    "Description": "S12r7: Bayer - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at a",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r8",
    "Description": "S12r8: Abbvie - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r11",
    "Description": "S12r11: Novartis - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r12",
    "Description": "S12r12: Daiichi-Sankyo - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, convers",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r13",
    "Description": "S12r13: Amgen - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r14",
    "Description": "S12r14: Seagen (Seattle Genetics) - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussi",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r15",
    "Description": "S12r15: GSK - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at a",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r16",
    "Description": "S12r16: AstraZeneca - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversati",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r17",
    "Description": "S12r17: Gilead - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12r18",
    "Description": "S12r18: Merck - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12"
  },
  {
    "Column": "S12ar2",
    "Description": "S12ar2: EMD Serono - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversatio",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar3",
    "Description": "S12ar3: Bristol-Myers Squibb (BMS) - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discuss",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar4",
    "Description": "S12ar4: Genentech - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar5",
    "Description": "S12ar5: Pfizer - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar6",
    "Description": "S12ar6: Janssen / Johnson & Johnson - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discus",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar7",
    "Description": "S12ar7: Bayer - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar8",
    "Description": "S12ar8: Abbvie - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar11",
    "Description": "S12ar11: Novartis - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar12",
    "Description": "S12ar12: Daiichi-Sankyo - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conver",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar13",
    "Description": "S12ar13: Amgen - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar14",
    "Description": "S12ar14: Seagen (Seattle Genetics) - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discuss",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar15",
    "Description": "S12ar15: GSK - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at a",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar16",
    "Description": "S12ar16: AstraZeneca - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversat",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar17",
    "Description": "S12ar17: Gilead - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation a",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "S12ar18",
    "Description": "S12ar18: Merck - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
    "Answer_Options": "1=Yes, have interacted in past 6 months,2=No, have not interacted in past 6 months",
    "ParentQuestion": "S12a"
  },
  {
    "Column": "hCompetitor1",
    "Description": "hCompetitor1: hCompetitor1",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck",
    "ParentQuestion": "hCompetito"
  },
  {
    "Column": "hCompetitor2",
    "Description": "hCompetitor2: hCompetitor2",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck",
    "ParentQuestion": "hCompetito"
  },
  {
    "Column": "hCompetitor3",
    "Description": "hCompetitor3: hCompetitor3",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck",
    "ParentQuestion": "hCompetito"
  },
  {
    "Column": "hCompetitorsr1",
    "Description": "hCompetitorsr1: Astellas - hCompetitors",
    "Answer_Options": "0=NO TO: Astellas,1=Astellas",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr2",
    "Description": "hCompetitorsr2: EMD Serono - hCompetitors",
    "Answer_Options": "0=NO TO: EMD Serono,1=EMD Serono",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr3",
    "Description": "hCompetitorsr3: Bristol-Myers Squibb (BMS) - hCompetitors",
    "Answer_Options": "0=NO TO: Bristol-Myers Squibb (BMS),1=Bristol-Myers Squibb (BMS)",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr4",
    "Description": "hCompetitorsr4: Genentech - hCompetitors",
    "Answer_Options": "0=NO TO: Genentech,1=Genentech",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr5",
    "Description": "hCompetitorsr5: Pfizer - hCompetitors",
    "Answer_Options": "0=NO TO: Pfizer,1=Pfizer",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr6",
    "Description": "hCompetitorsr6: Janssen / Johnson & Johnson - hCompetitors",
    "Answer_Options": "0=NO TO: Janssen / Johnson & Johnson,1=Janssen / Johnson & Johnson",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr7",
    "Description": "hCompetitorsr7: Bayer - hCompetitors",
    "Answer_Options": "0=NO TO: Bayer,1=Bayer",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr8",
    "Description": "hCompetitorsr8: Abbvie - hCompetitors",
    "Answer_Options": "0=NO TO: Abbvie,1=Abbvie",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr11",
    "Description": "hCompetitorsr11: Novartis - hCompetitors",
    "Answer_Options": "0=NO TO: Novartis,1=Novartis",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr12",
    "Description": "hCompetitorsr12: Daiichi-Sankyo - hCompetitors",
    "Answer_Options": "0=NO TO: Daiichi-Sankyo,1=Daiichi-Sankyo",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr13",
    "Description": "hCompetitorsr13: Amgen - hCompetitors",
    "Answer_Options": "0=NO TO: Amgen,1=Amgen",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr14",
    "Description": "hCompetitorsr14: Seagen (Seattle Genetics) - hCompetitors",
    "Answer_Options": "0=NO TO: Seagen (Seattle Genetics),1=Seagen (Seattle Genetics)",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr15",
    "Description": "hCompetitorsr15: GSK - hCompetitors",
    "Answer_Options": "0=NO TO: GSK,1=GSK",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr16",
    "Description": "hCompetitorsr16: AstraZeneca - hCompetitors",
    "Answer_Options": "0=NO TO: AstraZeneca,1=AstraZeneca",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr17",
    "Description": "hCompetitorsr17: Gilead - hCompetitors",
    "Answer_Options": "0=NO TO: Gilead,1=Gilead",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hCompetitorsr18",
    "Description": "hCompetitorsr18: Merck - hCompetitors",
    "Answer_Options": "0=NO TO: Merck,1=Merck",
    "ParentQuestion": "hCompetitors"
  },
  {
    "Column": "hS12aCompetitor1",
    "Description": "hS12aCompetitor1: hS12aCompetitor1",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck",
    "ParentQuestion": "hS12aCompetito"
  },
  {
    "Column": "hS12aCompetitorsr1",
    "Description": "hS12aCompetitorsr1: Astellas - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Astellas,1=Astellas",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr2",
    "Description": "hS12aCompetitorsr2: EMD Serono - hS12aCompetitors",
    "Answer_Options": "0=NO TO: EMD Serono,1=EMD Serono",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr3",
    "Description": "hS12aCompetitorsr3: Bristol-Myers Squibb (BMS) - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Bristol-Myers Squibb (BMS),1=Bristol-Myers Squibb (BMS)",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr4",
    "Description": "hS12aCompetitorsr4: Genentech - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Genentech,1=Genentech",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr5",
    "Description": "hS12aCompetitorsr5: Pfizer - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Pfizer,1=Pfizer",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr6",
    "Description": "hS12aCompetitorsr6: Janssen / Johnson & Johnson - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Janssen / Johnson & Johnson,1=Janssen / Johnson & Johnson",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr7",
    "Description": "hS12aCompetitorsr7: Bayer - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Bayer,1=Bayer",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr8",
    "Description": "hS12aCompetitorsr8: Abbvie - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Abbvie,1=Abbvie",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr11",
    "Description": "hS12aCompetitorsr11: Novartis - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Novartis,1=Novartis",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr12",
    "Description": "hS12aCompetitorsr12: Daiichi-Sankyo - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Daiichi-Sankyo,1=Daiichi-Sankyo",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr13",
    "Description": "hS12aCompetitorsr13: Amgen - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Amgen,1=Amgen",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr14",
    "Description": "hS12aCompetitorsr14: Seagen (Seattle Genetics) - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Seagen (Seattle Genetics),1=Seagen (Seattle Genetics)",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr15",
    "Description": "hS12aCompetitorsr15: GSK - hS12aCompetitors",
    "Answer_Options": "0=NO TO: GSK,1=GSK",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr16",
    "Description": "hS12aCompetitorsr16: AstraZeneca - hS12aCompetitors",
    "Answer_Options": "0=NO TO: AstraZeneca,1=AstraZeneca",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr17",
    "Description": "hS12aCompetitorsr17: Gilead - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Gilead,1=Gilead",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12aCompetitorsr18",
    "Description": "hS12aCompetitorsr18: Merck - hS12aCompetitors",
    "Answer_Options": "0=NO TO: Merck,1=Merck",
    "ParentQuestion": "hS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr1",
    "Description": "hS12XS12aCompetitorsr1: Astellas - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Astellas,1=Astellas",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr2",
    "Description": "hS12XS12aCompetitorsr2: EMD Serono - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: EMD Serono,1=EMD Serono",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr3",
    "Description": "hS12XS12aCompetitorsr3: Bristol-Myers Squibb (BMS) - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Bristol-Myers Squibb (BMS),1=Bristol-Myers Squibb (BMS)",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr4",
    "Description": "hS12XS12aCompetitorsr4: Genentech - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Genentech,1=Genentech",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr5",
    "Description": "hS12XS12aCompetitorsr5: Pfizer - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Pfizer,1=Pfizer",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr6",
    "Description": "hS12XS12aCompetitorsr6: Janssen / Johnson & Johnson - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Janssen / Johnson & Johnson,1=Janssen / Johnson & Johnson",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr7",
    "Description": "hS12XS12aCompetitorsr7: Bayer - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Bayer,1=Bayer",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr8",
    "Description": "hS12XS12aCompetitorsr8: Abbvie - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Abbvie,1=Abbvie",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr11",
    "Description": "hS12XS12aCompetitorsr11: Novartis - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Novartis,1=Novartis",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr12",
    "Description": "hS12XS12aCompetitorsr12: Daiichi-Sankyo - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Daiichi-Sankyo,1=Daiichi-Sankyo",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr13",
    "Description": "hS12XS12aCompetitorsr13: Amgen - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Amgen,1=Amgen",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr14",
    "Description": "hS12XS12aCompetitorsr14: Seagen (Seattle Genetics) - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Seagen (Seattle Genetics),1=Seagen (Seattle Genetics)",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr15",
    "Description": "hS12XS12aCompetitorsr15: GSK - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: GSK,1=GSK",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr16",
    "Description": "hS12XS12aCompetitorsr16: AstraZeneca - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: AstraZeneca,1=AstraZeneca",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr17",
    "Description": "hS12XS12aCompetitorsr17: Gilead - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Gilead,1=Gilead",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "hS12XS12aCompetitorsr18",
    "Description": "hS12XS12aCompetitorsr18: Merck - hS12XS12aCompetitors",
    "Answer_Options": "0=NO TO: Merck,1=Merck",
    "ParentQuestion": "hS12XS12aCompetitors"
  },
  {
    "Column": "SpecialtyTypeQuota",
    "Description": "SpecialtyTypeQuota: SpecialtyTypeQuota",
    "Answer_Options": "1=S3=2 HEM ONC OR S3a=1 OR S3=7 MED ONC,2=S3a=2 URO OR S3=4,3=S9a=3,4,6"
  },
  {
    "Column": "OncType_Total",
    "Description": "OncType_Total: OncType_Total",
    "Answer_Options": "1=Hem Oncs S3=2 HEM ONC,2=Med Oncs S3a=1 OR S3=7 MED ONC"
  },
  {
    "Column": "hS7_CTreater_PC",
    "Description": "hS7_CTreater_PC: hS7_CTreater_PC",
    "Answer_Options": "1=ONC PC Treaters,2=ONC Non-PC Treater"
  },
  {
    "Column": "hS7_CTreater_BC",
    "Description": "hS7_CTreater_BC: hS7_CTreater_BC",
    "Answer_Options": "1=ONC BC Treaters,2=ONC Non-BC Treater"
  },
  {
    "Column": "hS7_CTreater_AML",
    "Description": "hS7_CTreater_AML: hS7_CTreater_AML",
    "Answer_Options": "1=ONC AML Treaters,2=ONC Non-AML Treater"
  },
  {
    "Column": "hS10Treater_PC",
    "Description": "hS10Treater_PC: hS10Treater_PC",
    "Answer_Options": "1=AHP PC Treaters,2=AHP Non-PC Treater"
  },
  {
    "Column": "hS10Treater_BC",
    "Description": "hS10Treater_BC: hS10Treater_BC",
    "Answer_Options": "1=AHP BC Treaters,2=AHP Non-BC Treater"
  },
  {
    "Column": "hS10Treater_AML",
    "Description": "hS10Treater_AML: hS10Treater_AML",
    "Answer_Options": "1=AHP AML Treaters,2=AHP Non-AML Treater"
  },
  {
    "Column": "Q1c1r1",
    "Description": "Q1c1r1: Astellas - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology dr",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r2",
    "Description": "Q1c1r2: EMD Serono - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r3",
    "Description": "Q1c1r3: Bristol-Myers Squibb (BMS) - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company rela",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r4",
    "Description": "Q1c1r4: Genentech - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology d",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r5",
    "Description": "Q1c1r5: Pfizer - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology drug",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r6",
    "Description": "Q1c1r6: Janssen / Johnson & Johnson - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company rel",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r7",
    "Description": "Q1c1r7: Bayer - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology drugs",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r8",
    "Description": "Q1c1r8: Abbvie - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology drug",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r11",
    "Description": "Q1c1r11: Novartis - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology d",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r12",
    "Description": "Q1c1r12: Daiichi-Sankyo - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to onco",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r13",
    "Description": "Q1c1r13: Amgen - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology drug",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r14",
    "Description": "Q1c1r14: Seagen (Seattle Genetics) - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company rela",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r15",
    "Description": "Q1c1r15: GSK - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology drugs",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r16",
    "Description": "Q1c1r16: AstraZeneca - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncolog",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r17",
    "Description": "Q1c1r17: Gilead - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology dru",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q1c1r18",
    "Description": "Q1c1r18: Merck - You indicated that you have interacted with the following companies in the past 6 months: [pipe:hS12XS12aCompetitors]. For each of these companies, approximately how many times have you interacted with the company related to oncology drug",
    "Answer_Options": "NA",
    "ParentQuestion": "Q1c1"
  },
  {
    "Column": "Q2c1",
    "Description": "Q2c1: Astellas - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c2",
    "Description": "Q2c2: EMD Serono - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c3",
    "Description": "Q2c3: Bristol-Myers Squibb (BMS) - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c4",
    "Description": "Q2c4: Genentech - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c5",
    "Description": "Q2c5: Pfizer - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c6",
    "Description": "Q2c6: Janssen / Johnson & Johnson - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c7",
    "Description": "Q2c7: Bayer - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c8",
    "Description": "Q2c8: Abbvie - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c11",
    "Description": "Q2c11: Novartis - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c12",
    "Description": "Q2c12: Daiichi-Sankyo - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c13",
    "Description": "Q2c13: Amgen - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c14",
    "Description": "Q2c14: Seagen (Seattle Genetics) - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c15",
    "Description": "Q2c15: GSK - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c16",
    "Description": "Q2c16: AstraZeneca - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c17",
    "Description": "Q2c17: Gilead - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q2c18",
    "Description": "Q2c18: Merck - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
    "Answer_Options": "1=Within the past week,2=2-3 weeks ago,3=1-3 months ago,4=Between 3 and 6 months ago",
    "ParentQuestion": "Q2"
  },
  {
    "Column": "Q3r1c1",
    "Description": "Q3r1c1: In-person discussion (i.e. at practice setting) - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c1",
    "Description": "Q3r8c1: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c1",
    "Description": "Q3r2c1: Telephone call - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c1",
    "Description": "Q3r3c1: Email communication - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c1",
    "Description": "Q3r4c1: Conference discussion (e.g., virtual or live booth visit, meeting) - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c1",
    "Description": "Q3r5c1: Website / Online portal - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c1",
    "Description": "Q3r9c1: Social media - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c1",
    "Description": "Q3r6c1: Other type of interaction (Specify): - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c1",
    "Description": "Q3r7c1: Other type of interaction (Specify): - Astellas - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c2",
    "Description": "Q3r1c2: In-person discussion (i.e. at practice setting) - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c2",
    "Description": "Q3r8c2: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c2",
    "Description": "Q3r2c2: Telephone call - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c2",
    "Description": "Q3r3c2: Email communication - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c2",
    "Description": "Q3r4c2: Conference discussion (e.g., virtual or live booth visit, meeting) - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c2",
    "Description": "Q3r5c2: Website / Online portal - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c2",
    "Description": "Q3r9c2: Social media - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c2",
    "Description": "Q3r6c2: Other type of interaction (Specify): - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c2",
    "Description": "Q3r7c2: Other type of interaction (Specify): - EMD Serono - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c3",
    "Description": "Q3r1c3: In-person discussion (i.e. at practice setting) - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c3",
    "Description": "Q3r8c3: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 mo",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c3",
    "Description": "Q3r2c3: Telephone call - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c3",
    "Description": "Q3r3c3: Email communication - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c3",
    "Description": "Q3r4c3: Conference discussion (e.g., virtual or live booth visit, meeting) - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the p",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c3",
    "Description": "Q3r5c3: Website / Online portal - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c3",
    "Description": "Q3r9c3: Social media - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c3",
    "Description": "Q3r6c3: Other type of interaction (Specify): - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c3",
    "Description": "Q3r7c3: Other type of interaction (Specify): - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c4",
    "Description": "Q3r1c4: In-person discussion (i.e. at practice setting) - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c4",
    "Description": "Q3r8c4: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c4",
    "Description": "Q3r2c4: Telephone call - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c4",
    "Description": "Q3r3c4: Email communication - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c4",
    "Description": "Q3r4c4: Conference discussion (e.g., virtual or live booth visit, meeting) - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c4",
    "Description": "Q3r5c4: Website / Online portal - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c4",
    "Description": "Q3r9c4: Social media - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c4",
    "Description": "Q3r6c4: Other type of interaction (Specify): - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c4",
    "Description": "Q3r7c4: Other type of interaction (Specify): - Genentech - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c5",
    "Description": "Q3r1c5: In-person discussion (i.e. at practice setting) - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c5",
    "Description": "Q3r8c5: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c5",
    "Description": "Q3r2c5: Telephone call - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c5",
    "Description": "Q3r3c5: Email communication - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c5",
    "Description": "Q3r4c5: Conference discussion (e.g., virtual or live booth visit, meeting) - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c5",
    "Description": "Q3r5c5: Website / Online portal - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c5",
    "Description": "Q3r9c5: Social media - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c5",
    "Description": "Q3r6c5: Other type of interaction (Specify): - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c5",
    "Description": "Q3r7c5: Other type of interaction (Specify): - Pfizer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c6",
    "Description": "Q3r1c6: In-person discussion (i.e. at practice setting) - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c6",
    "Description": "Q3r8c6: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 m",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c6",
    "Description": "Q3r2c6: Telephone call - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c6",
    "Description": "Q3r3c6: Email communication - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c6",
    "Description": "Q3r4c6: Conference discussion (e.g., virtual or live booth visit, meeting) - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c6",
    "Description": "Q3r5c6: Website / Online portal - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c6",
    "Description": "Q3r9c6: Social media - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c6",
    "Description": "Q3r6c6: Other type of interaction (Specify): - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c6",
    "Description": "Q3r7c6: Other type of interaction (Specify): - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c7",
    "Description": "Q3r1c7: In-person discussion (i.e. at practice setting) - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c7",
    "Description": "Q3r8c7: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c7",
    "Description": "Q3r2c7: Telephone call - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c7",
    "Description": "Q3r3c7: Email communication - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c7",
    "Description": "Q3r4c7: Conference discussion (e.g., virtual or live booth visit, meeting) - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c7",
    "Description": "Q3r5c7: Website / Online portal - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c7",
    "Description": "Q3r9c7: Social media - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c7",
    "Description": "Q3r6c7: Other type of interaction (Specify): - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c7",
    "Description": "Q3r7c7: Other type of interaction (Specify): - Bayer - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c8",
    "Description": "Q3r1c8: In-person discussion (i.e. at practice setting) - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c8",
    "Description": "Q3r8c8: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c8",
    "Description": "Q3r2c8: Telephone call - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c8",
    "Description": "Q3r3c8: Email communication - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c8",
    "Description": "Q3r4c8: Conference discussion (e.g., virtual or live booth visit, meeting) - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c8",
    "Description": "Q3r5c8: Website / Online portal - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c8",
    "Description": "Q3r9c8: Social media - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c8",
    "Description": "Q3r6c8: Other type of interaction (Specify): - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c8",
    "Description": "Q3r7c8: Other type of interaction (Specify): - Abbvie - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c11",
    "Description": "Q3r1c11: In-person discussion (i.e. at practice setting) - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c11",
    "Description": "Q3r8c11: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c11",
    "Description": "Q3r2c11: Telephone call - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c11",
    "Description": "Q3r3c11: Email communication - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c11",
    "Description": "Q3r4c11: Conference discussion (e.g., virtual or live booth visit, meeting) - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c11",
    "Description": "Q3r5c11: Website / Online portal - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c11",
    "Description": "Q3r9c11: Social media - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c11",
    "Description": "Q3r6c11: Other type of interaction (Specify): - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c11",
    "Description": "Q3r7c11: Other type of interaction (Specify): - Novartis - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c12",
    "Description": "Q3r1c12: In-person discussion (i.e. at practice setting) - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c12",
    "Description": "Q3r8c12: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c12",
    "Description": "Q3r2c12: Telephone call - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c12",
    "Description": "Q3r3c12: Email communication - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c12",
    "Description": "Q3r4c12: Conference discussion (e.g., virtual or live booth visit, meeting) - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 month",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c12",
    "Description": "Q3r5c12: Website / Online portal - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c12",
    "Description": "Q3r9c12: Social media - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c12",
    "Description": "Q3r6c12: Other type of interaction (Specify): - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c12",
    "Description": "Q3r7c12: Other type of interaction (Specify): - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c13",
    "Description": "Q3r1c13: In-person discussion (i.e. at practice setting) - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c13",
    "Description": "Q3r8c13: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c13",
    "Description": "Q3r2c13: Telephone call - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c13",
    "Description": "Q3r3c13: Email communication - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c13",
    "Description": "Q3r4c13: Conference discussion (e.g., virtual or live booth visit, meeting) - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c13",
    "Description": "Q3r5c13: Website / Online portal - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c13",
    "Description": "Q3r9c13: Social media - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c13",
    "Description": "Q3r6c13: Other type of interaction (Specify): - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c13",
    "Description": "Q3r7c13: Other type of interaction (Specify): - Amgen - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c14",
    "Description": "Q3r1c14: In-person discussion (i.e. at practice setting) - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c14",
    "Description": "Q3r8c14: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 mo",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c14",
    "Description": "Q3r2c14: Telephone call - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c14",
    "Description": "Q3r3c14: Email communication - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c14",
    "Description": "Q3r4c14: Conference discussion (e.g., virtual or live booth visit, meeting) - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the p",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c14",
    "Description": "Q3r5c14: Website / Online portal - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c14",
    "Description": "Q3r9c14: Social media - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c14",
    "Description": "Q3r6c14: Other type of interaction (Specify): - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c14",
    "Description": "Q3r7c14: Other type of interaction (Specify): - Seagen (Seattle Genetics) - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c15",
    "Description": "Q3r1c15: In-person discussion (i.e. at practice setting) - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c15",
    "Description": "Q3r8c15: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c15",
    "Description": "Q3r2c15: Telephone call - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c15",
    "Description": "Q3r3c15: Email communication - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c15",
    "Description": "Q3r4c15: Conference discussion (e.g., virtual or live booth visit, meeting) - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c15",
    "Description": "Q3r5c15: Website / Online portal - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c15",
    "Description": "Q3r9c15: Social media - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c15",
    "Description": "Q3r6c15: Other type of interaction (Specify): - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c15",
    "Description": "Q3r7c15: Other type of interaction (Specify): - GSK - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c16",
    "Description": "Q3r1c16: In-person discussion (i.e. at practice setting) - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c16",
    "Description": "Q3r8c16: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c16",
    "Description": "Q3r2c16: Telephone call - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c16",
    "Description": "Q3r3c16: Email communication - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c16",
    "Description": "Q3r4c16: Conference discussion (e.g., virtual or live booth visit, meeting) - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c16",
    "Description": "Q3r5c16: Website / Online portal - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c16",
    "Description": "Q3r9c16: Social media - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c16",
    "Description": "Q3r6c16: Other type of interaction (Specify): - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c16",
    "Description": "Q3r7c16: Other type of interaction (Specify): - AstraZeneca - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c17",
    "Description": "Q3r1c17: In-person discussion (i.e. at practice setting) - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c17",
    "Description": "Q3r8c17: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c17",
    "Description": "Q3r2c17: Telephone call - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c17",
    "Description": "Q3r3c17: Email communication - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c17",
    "Description": "Q3r4c17: Conference discussion (e.g., virtual or live booth visit, meeting) - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c17",
    "Description": "Q3r5c17: Website / Online portal - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c17",
    "Description": "Q3r9c17: Social media - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c17",
    "Description": "Q3r6c17: Other type of interaction (Specify): - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c17",
    "Description": "Q3r7c17: Other type of interaction (Specify): - Gilead - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r1c18",
    "Description": "Q3r1c18: In-person discussion (i.e. at practice setting) - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: In-person discussion (i.e. at practice setting),1=In-person discussion (i.e. at practice setting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r8c18",
    "Description": "Q3r8c18: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),1=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r2c18",
    "Description": "Q3r2c18: Telephone call - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Telephone call,1=Telephone call",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r3c18",
    "Description": "Q3r3c18: Email communication - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Email communication,1=Email communication",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r4c18",
    "Description": "Q3r4c18: Conference discussion (e.g., virtual or live booth visit, meeting) - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Conference discussion (e.g., virtual or live booth visit, meeting),1=Conference discussion (e.g., virtual or live booth visit, meeting)",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r5c18",
    "Description": "Q3r5c18: Website / Online portal - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Website / Online portal,1=Website / Online portal",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r9c18",
    "Description": "Q3r9c18: Social media - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Social media,1=Social media",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6c18",
    "Description": "Q3r6c18: Other type of interaction (Specify): - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7c18",
    "Description": "Q3r7c18: Other type of interaction (Specify): - Merck - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of interaction (Specify):,1=Other type of interaction (Specify):",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r6oe",
    "Description": "Q3r6oe: Other type of interaction (Specify): - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3r7oe",
    "Description": "Q3r7oe: Other type of interaction (Specify): - For each of these companies, please indicate all the types of interactions/encounters you have had with them related to their oncology drugs in the past 6 months.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q3"
  },
  {
    "Column": "Q3ar1c1",
    "Description": "Q3ar1c1: Product sales representative - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c1",
    "Description": "Q3ar2c1: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel yo",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c1",
    "Description": "Q3ar8c1: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Astellas - For each of these companies, to the best of your ability, please in",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c1",
    "Description": "Q3ar9c1: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inte",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c1",
    "Description": "Q3ar3c1: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c1",
    "Description": "Q3ar4c1: Other type of person (Specify): - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c1",
    "Description": "Q3ar5c1: Other type of person (Specify): - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c2",
    "Description": "Q3ar1c2: Product sales representative - EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c2",
    "Description": "Q3ar2c2: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c2",
    "Description": "Q3ar8c2: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - EMD Serono - For each of these companies, to the best of your ability, please",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c2",
    "Description": "Q3ar9c2: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have in",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c2",
    "Description": "Q3ar3c2: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inter",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c2",
    "Description": "Q3ar4c2: Other type of person (Specify): - EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c2",
    "Description": "Q3ar5c2: Other type of person (Specify): - EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c3",
    "Description": "Q3ar1c3: Product sales representative - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c3",
    "Description": "Q3ar2c3: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the typ",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c3",
    "Description": "Q3ar8c3: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c3",
    "Description": "Q3ar9c3: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of perso",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c3",
    "Description": "Q3ar3c3: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personne",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c3",
    "Description": "Q3ar4c3: Other type of person (Specify): - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c3",
    "Description": "Q3ar5c3: Other type of person (Specify): - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c4",
    "Description": "Q3ar1c4: Product sales representative - Genentech - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c4",
    "Description": "Q3ar2c4: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Genentech - For each of these companies, to the best of your ability, please indicate all the types of personnel y",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c4",
    "Description": "Q3ar8c4: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Genentech - For each of these companies, to the best of your ability, please i",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c4",
    "Description": "Q3ar9c4: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Genentech - For each of these companies, to the best of your ability, please indicate all the types of personnel you have int",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c4",
    "Description": "Q3ar3c4: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Genentech - For each of these companies, to the best of your ability, please indicate all the types of personnel you have intera",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c4",
    "Description": "Q3ar4c4: Other type of person (Specify): - Genentech - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c4",
    "Description": "Q3ar5c4: Other type of person (Specify): - Genentech - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c5",
    "Description": "Q3ar1c5: Product sales representative - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c5",
    "Description": "Q3ar2c5: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c5",
    "Description": "Q3ar8c5: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Pfizer - For each of these companies, to the best of your ability, please indi",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c5",
    "Description": "Q3ar9c5: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have intera",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c5",
    "Description": "Q3ar3c5: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacte",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c5",
    "Description": "Q3ar4c5: Other type of person (Specify): - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c5",
    "Description": "Q3ar5c5: Other type of person (Specify): - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c6",
    "Description": "Q3ar1c6: Product sales representative - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c6",
    "Description": "Q3ar2c6: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the ty",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c6",
    "Description": "Q3ar8c6: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Janssen / Johnson & Johnson - For each of these companies, to the best of your",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c6",
    "Description": "Q3ar9c6: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of pers",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c6",
    "Description": "Q3ar3c6: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personn",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c6",
    "Description": "Q3ar4c6: Other type of person (Specify): - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c6",
    "Description": "Q3ar5c6: Other type of person (Specify): - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c7",
    "Description": "Q3ar1c7: Product sales representative - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c7",
    "Description": "Q3ar2c7: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you h",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c7",
    "Description": "Q3ar8c7: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Bayer - For each of these companies, to the best of your ability, please indic",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c7",
    "Description": "Q3ar9c7: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c7",
    "Description": "Q3ar3c7: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c7",
    "Description": "Q3ar4c7: Other type of person (Specify): - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c7",
    "Description": "Q3ar5c7: Other type of person (Specify): - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c8",
    "Description": "Q3ar1c8: Product sales representative - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c8",
    "Description": "Q3ar2c8: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c8",
    "Description": "Q3ar8c8: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Abbvie - For each of these companies, to the best of your ability, please indi",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c8",
    "Description": "Q3ar9c8: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have intera",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c8",
    "Description": "Q3ar3c8: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacte",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c8",
    "Description": "Q3ar4c8: Other type of person (Specify): - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c8",
    "Description": "Q3ar5c8: Other type of person (Specify): - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c11",
    "Description": "Q3ar1c11: Product sales representative - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c11",
    "Description": "Q3ar2c11: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel y",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c11",
    "Description": "Q3ar8c11: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Novartis - For each of these companies, to the best of your ability, please i",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c11",
    "Description": "Q3ar9c11: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have int",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c11",
    "Description": "Q3ar3c11: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have intera",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c11",
    "Description": "Q3ar4c11: Other type of person (Specify): - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c11",
    "Description": "Q3ar5c11: Other type of person (Specify): - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c12",
    "Description": "Q3ar1c12: Product sales representative - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c12",
    "Description": "Q3ar2c12: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of perso",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c12",
    "Description": "Q3ar8c12: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Daiichi-Sankyo - For each of these companies, to the best of your ability, pl",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c12",
    "Description": "Q3ar9c12: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you ha",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c12",
    "Description": "Q3ar3c12: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c12",
    "Description": "Q3ar4c12: Other type of person (Specify): - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c12",
    "Description": "Q3ar5c12: Other type of person (Specify): - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c13",
    "Description": "Q3ar1c13: Product sales representative - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c13",
    "Description": "Q3ar2c13: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c13",
    "Description": "Q3ar8c13: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Amgen - For each of these companies, to the best of your ability, please indi",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c13",
    "Description": "Q3ar9c13: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have intera",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c13",
    "Description": "Q3ar3c13: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacte",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c13",
    "Description": "Q3ar4c13: Other type of person (Specify): - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c13",
    "Description": "Q3ar5c13: Other type of person (Specify): - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c14",
    "Description": "Q3ar1c14: Product sales representative - Seagen (Seattle Genetics) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c14",
    "Description": "Q3ar2c14: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Seagen (Seattle Genetics) - For each of these companies, to the best of your ability, please indicate all the typ",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c14",
    "Description": "Q3ar8c14: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Seagen (Seattle Genetics) - For each of these companies, to the best of your",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c14",
    "Description": "Q3ar9c14: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Seagen (Seattle Genetics) - For each of these companies, to the best of your ability, please indicate all the types of perso",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c14",
    "Description": "Q3ar3c14: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Seagen (Seattle Genetics) - For each of these companies, to the best of your ability, please indicate all the types of personne",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c14",
    "Description": "Q3ar4c14: Other type of person (Specify): - Seagen (Seattle Genetics) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c14",
    "Description": "Q3ar5c14: Other type of person (Specify): - Seagen (Seattle Genetics) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c15",
    "Description": "Q3ar1c15: Product sales representative - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c15",
    "Description": "Q3ar2c15: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you ha",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c15",
    "Description": "Q3ar8c15: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - GSK - For each of these companies, to the best of your ability, please indica",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c15",
    "Description": "Q3ar9c15: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interact",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c15",
    "Description": "Q3ar3c15: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c15",
    "Description": "Q3ar4c15: Other type of person (Specify): - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c15",
    "Description": "Q3ar5c15: Other type of person (Specify): - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c16",
    "Description": "Q3ar1c16: Product sales representative - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c16",
    "Description": "Q3ar2c16: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personne",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c16",
    "Description": "Q3ar8c16: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - AstraZeneca - For each of these companies, to the best of your ability, pleas",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c16",
    "Description": "Q3ar9c16: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c16",
    "Description": "Q3ar3c16: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have int",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c16",
    "Description": "Q3ar4c16: Other type of person (Specify): - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c16",
    "Description": "Q3ar5c16: Other type of person (Specify): - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c17",
    "Description": "Q3ar1c17: Product sales representative - Gilead - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c17",
    "Description": "Q3ar2c17: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Gilead - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c17",
    "Description": "Q3ar8c17: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Gilead - For each of these companies, to the best of your ability, please ind",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c17",
    "Description": "Q3ar9c17: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Gilead - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inter",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c17",
    "Description": "Q3ar3c17: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Gilead - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interact",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c17",
    "Description": "Q3ar4c17: Other type of person (Specify): - Gilead - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c17",
    "Description": "Q3ar5c17: Other type of person (Specify): - Gilead - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar1c18",
    "Description": "Q3ar1c18: Product sales representative - Merck - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Product sales representative,1=Product sales representative",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar2c18",
    "Description": "Q3ar2c18: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare providers) - Merck - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
    "Answer_Options": "0=NO TO: Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healt,1=Medical science liaison (MSL) (i.e. medical affairs personnel whose main responsibility is interacting with healthcare p",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar8c18",
    "Description": "Q3ar8c18: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Merck - For each of these companies, to the best of your ability, please indi",
    "Answer_Options": "0=NO TO: Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issu,1=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar9c18",
    "Description": "Q3ar9c18: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement) - Merck - For each of these companies, to the best of your ability, please indicate all the types of personnel you have intera",
    "Answer_Options": "0=NO TO: Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimburse,1=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar3c18",
    "Description": "Q3ar3c18: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.) - Merck - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacte",
    "Answer_Options": "0=NO TO: Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc,1=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.)",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4c18",
    "Description": "Q3ar4c18: Other type of person (Specify): - Merck - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5c18",
    "Description": "Q3ar5c18: Other type of person (Specify): - Merck - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "0=NO TO: Other type of person (Specify):,1=Other type of person (Specify):",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar4oe",
    "Description": "Q3ar4oe: Other type of person (Specify): - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q3ar5oe",
    "Description": "Q3ar5oe: Other type of person (Specify): - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q3a"
  },
  {
    "Column": "Q4r1",
    "Description": "Q4r1: Is a company I trust - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs. It is important",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r2",
    "Description": "Q4r2: Puts patients first - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs. It is important",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r3",
    "Description": "Q4r3: Enables timely and reliable access to medications - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceutical company with on",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r4",
    "Description": "Q4r4: Provides a breadth of financial assistance options for patients - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceutical c",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r5",
    "Description": "Q4r5: Invests in oncology clinical trials/pipeline - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceutical company with oncolog",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r6",
    "Description": "Q4r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes ar",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r7",
    "Description": "Q4r7: Provides support services (non-financial) to patients and caregivers - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceuti",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r8",
    "Description": "Q4r8: Has a useful and easy-to-use website - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs.",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r9",
    "Description": "Q4r9: Is focused on developing treatments for cancers with limited treatment options - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attributes are for a p",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4r10",
    "Description": "Q4r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Please think about the pharmaceutical companies that you interact with most often for oncology drugs. Please indicate how important the following attribute",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q4"
  },
  {
    "Column": "Q4a",
    "Description": "Q4a: And, of the attributes below, please indicate which ONE is most important to you when interacting with companies regarding their oncology drugs.",
    "Answer_Options": "1=Is a company I trust,2=Puts patients first,3=Enables timely and reliable access to medications,4=Provides a breadth of financial assistance options for patients,5=Invests in oncology clinical trials/pipeline,6=Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"},7=Provides support services (non-financial) to patients and caregivers,8=Has a useful and easy-to-use website,9=Is focused on developing treatments for cancers with limited treatment options,10=Demonstrates corporate or social responsibility through community involvement/partnerships"
  },
  {
    "Column": "Q5r1",
    "Description": "Q5r1: Have a presence in my practice / regular touchpoints - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r2",
    "Description": "Q5r2: Demonstrate in-depth knowledge of treatment area - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r3",
    "Description": "Q5r3: Deliver quality product information and education - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r4",
    "Description": "Q5r4: Understand my practice - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you might interact with). Plea",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r5",
    "Description": "Q5r5: Are responsive and dependable - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you might interact with",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r6",
    "Description": "Q5r6: Are collaborative - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you might interact with). Please in",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r7",
    "Description": "Q5r7: Are helpful in securing timely product access - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you mig",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r8",
    "Description": "Q5r8: Make my job easier by reducing hassles to prescribing - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r9",
    "Description": "Q5r9: Provides information that is helpful in making my treatment decisions - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any o",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r10",
    "Description": "Q5r10: Are warm and friendly - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you might interact with). Plea",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r11",
    "Description": "Q5r11: Tailors interactions and information delivery to my individual needs - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any o",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5r12",
    "Description": "Q5r12: Respects my time - Now please think about the personnel from these companies (including sales representatives, account managers, medical science liaisons, access/ reimbursement managers, and any other people that you might interact with). Please in",
    "Answer_Options": "1=1 - Not at all Important,2=2,3=3,4=5,6=6,7=7,8=8,9=9,10=10 - Extremely important",
    "ParentQuestion": "Q5"
  },
  {
    "Column": "Q5a",
    "Description": "Q5a: And, of the attributes below, please indicate which ONE is most important to you when interacting with the people from a pharmaceutical company regarding their oncology drugs.",
    "Answer_Options": "1=Have a presence in my practice / frequent touchpoints,2=Demonstrate in-depth knowledge of treatment area,3=Deliver quality product information and education,4=Understand my practice,5=Are responsive and dependable,6=Are collaborative,7=Are helpful in securing timely product access,8=Make my job easier by reducing hassles to prescribing,9=Give me confidence I am making the right treatment decisions,10=Are warm and friendly,11=Are adaptable to the current environment,12=Respects my time"
  },
  {
    "Column": "Q6_1r1",
    "Description": "Q6_1r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r2",
    "Description": "Q6_1r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r3",
    "Description": "Q6_1r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r4",
    "Description": "Q6_1r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r5",
    "Description": "Q6_1r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r6",
    "Description": "Q6_1r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r7",
    "Description": "Q6_1r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r8",
    "Description": "Q6_1r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r9",
    "Description": "Q6_1r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_1r10",
    "Description": "Q6_1r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_1"
  },
  {
    "Column": "Q6_2r1",
    "Description": "Q6_2r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r2",
    "Description": "Q6_2r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r3",
    "Description": "Q6_2r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r4",
    "Description": "Q6_2r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r5",
    "Description": "Q6_2r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r6",
    "Description": "Q6_2r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r7",
    "Description": "Q6_2r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r8",
    "Description": "Q6_2r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r9",
    "Description": "Q6_2r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_2r10",
    "Description": "Q6_2r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_2"
  },
  {
    "Column": "Q6_3r1",
    "Description": "Q6_3r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r2",
    "Description": "Q6_3r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r3",
    "Description": "Q6_3r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r4",
    "Description": "Q6_3r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r5",
    "Description": "Q6_3r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r6",
    "Description": "Q6_3r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r7",
    "Description": "Q6_3r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r8",
    "Description": "Q6_3r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r9",
    "Description": "Q6_3r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_3r10",
    "Description": "Q6_3r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_3"
  },
  {
    "Column": "Q6_4r1",
    "Description": "Q6_4r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r2",
    "Description": "Q6_4r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r3",
    "Description": "Q6_4r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r4",
    "Description": "Q6_4r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r5",
    "Description": "Q6_4r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r6",
    "Description": "Q6_4r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r7",
    "Description": "Q6_4r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r8",
    "Description": "Q6_4r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r9",
    "Description": "Q6_4r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_4r10",
    "Description": "Q6_4r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_4"
  },
  {
    "Column": "Q6_5r1",
    "Description": "Q6_5r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r2",
    "Description": "Q6_5r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r3",
    "Description": "Q6_5r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r4",
    "Description": "Q6_5r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r5",
    "Description": "Q6_5r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r6",
    "Description": "Q6_5r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r7",
    "Description": "Q6_5r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r8",
    "Description": "Q6_5r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r9",
    "Description": "Q6_5r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_5r10",
    "Description": "Q6_5r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_5"
  },
  {
    "Column": "Q6_6r1",
    "Description": "Q6_6r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r2",
    "Description": "Q6_6r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r3",
    "Description": "Q6_6r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r4",
    "Description": "Q6_6r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r5",
    "Description": "Q6_6r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r6",
    "Description": "Q6_6r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r7",
    "Description": "Q6_6r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r8",
    "Description": "Q6_6r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r9",
    "Description": "Q6_6r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_6r10",
    "Description": "Q6_6r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_6"
  },
  {
    "Column": "Q6_7r1",
    "Description": "Q6_7r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r2",
    "Description": "Q6_7r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r3",
    "Description": "Q6_7r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r4",
    "Description": "Q6_7r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r5",
    "Description": "Q6_7r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r6",
    "Description": "Q6_7r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r7",
    "Description": "Q6_7r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r8",
    "Description": "Q6_7r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r9",
    "Description": "Q6_7r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_7r10",
    "Description": "Q6_7r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_7"
  },
  {
    "Column": "Q6_8r1",
    "Description": "Q6_8r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r2",
    "Description": "Q6_8r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r3",
    "Description": "Q6_8r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r4",
    "Description": "Q6_8r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r5",
    "Description": "Q6_8r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r6",
    "Description": "Q6_8r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r7",
    "Description": "Q6_8r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r8",
    "Description": "Q6_8r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r9",
    "Description": "Q6_8r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_8r10",
    "Description": "Q6_8r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_8"
  },
  {
    "Column": "Q6_11r1",
    "Description": "Q6_11r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r2",
    "Description": "Q6_11r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r3",
    "Description": "Q6_11r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r4",
    "Description": "Q6_11r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r5",
    "Description": "Q6_11r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r6",
    "Description": "Q6_11r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r7",
    "Description": "Q6_11r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r8",
    "Description": "Q6_11r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r9",
    "Description": "Q6_11r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_11r10",
    "Description": "Q6_11r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_11"
  },
  {
    "Column": "Q6_12r1",
    "Description": "Q6_12r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r2",
    "Description": "Q6_12r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r3",
    "Description": "Q6_12r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r4",
    "Description": "Q6_12r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r5",
    "Description": "Q6_12r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r6",
    "Description": "Q6_12r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r7",
    "Description": "Q6_12r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r8",
    "Description": "Q6_12r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r9",
    "Description": "Q6_12r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_12r10",
    "Description": "Q6_12r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_12"
  },
  {
    "Column": "Q6_13r1",
    "Description": "Q6_13r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r2",
    "Description": "Q6_13r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r3",
    "Description": "Q6_13r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r4",
    "Description": "Q6_13r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r5",
    "Description": "Q6_13r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r6",
    "Description": "Q6_13r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r7",
    "Description": "Q6_13r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r8",
    "Description": "Q6_13r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r9",
    "Description": "Q6_13r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_13r10",
    "Description": "Q6_13r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_13"
  },
  {
    "Column": "Q6_14r1",
    "Description": "Q6_14r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r2",
    "Description": "Q6_14r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r3",
    "Description": "Q6_14r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r4",
    "Description": "Q6_14r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r5",
    "Description": "Q6_14r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r6",
    "Description": "Q6_14r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r7",
    "Description": "Q6_14r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r8",
    "Description": "Q6_14r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r9",
    "Description": "Q6_14r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_14r10",
    "Description": "Q6_14r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_14"
  },
  {
    "Column": "Q6_15r1",
    "Description": "Q6_15r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r2",
    "Description": "Q6_15r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r3",
    "Description": "Q6_15r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r4",
    "Description": "Q6_15r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r5",
    "Description": "Q6_15r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r6",
    "Description": "Q6_15r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r7",
    "Description": "Q6_15r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r8",
    "Description": "Q6_15r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r9",
    "Description": "Q6_15r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_15r10",
    "Description": "Q6_15r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_15"
  },
  {
    "Column": "Q6_16r1",
    "Description": "Q6_16r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r2",
    "Description": "Q6_16r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r3",
    "Description": "Q6_16r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r4",
    "Description": "Q6_16r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r5",
    "Description": "Q6_16r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r6",
    "Description": "Q6_16r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r7",
    "Description": "Q6_16r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r8",
    "Description": "Q6_16r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r9",
    "Description": "Q6_16r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_16r10",
    "Description": "Q6_16r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_16"
  },
  {
    "Column": "Q6_17r1",
    "Description": "Q6_17r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r2",
    "Description": "Q6_17r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r3",
    "Description": "Q6_17r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r4",
    "Description": "Q6_17r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r5",
    "Description": "Q6_17r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r6",
    "Description": "Q6_17r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r7",
    "Description": "Q6_17r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r8",
    "Description": "Q6_17r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r9",
    "Description": "Q6_17r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_17r10",
    "Description": "Q6_17r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_17"
  },
  {
    "Column": "Q6_18r1",
    "Description": "Q6_18r1: Is a company I trust - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r2",
    "Description": "Q6_18r2: Puts patients first - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r3",
    "Description": "Q6_18r3: Enables timely and reliable access to medications - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r4",
    "Description": "Q6_18r4: Provides a breadth of financial assistance options for patients - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r5",
    "Description": "Q6_18r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r6",
    "Description": "Q6_18r6: Has a portfolio of products that are relevant for $ {\"me\" if hS2.r1 else \"my practice\"} - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r7",
    "Description": "Q6_18r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r8",
    "Description": "Q6_18r8: Has a useful and easy-to-use website - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r9",
    "Description": "Q6_18r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q6_18r10",
    "Description": "Q6_18r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with on the following attributes.",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q6_18"
  },
  {
    "Column": "Q7_1r1",
    "Description": "Q7_1r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r2",
    "Description": "Q7_1r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r3",
    "Description": "Q7_1r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r4",
    "Description": "Q7_1r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r5",
    "Description": "Q7_1r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r6",
    "Description": "Q7_1r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r7",
    "Description": "Q7_1r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r8",
    "Description": "Q7_1r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r9",
    "Description": "Q7_1r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r10",
    "Description": "Q7_1r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r11",
    "Description": "Q7_1r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_1r12",
    "Description": "Q7_1r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_1"
  },
  {
    "Column": "Q7_2r1",
    "Description": "Q7_2r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r2",
    "Description": "Q7_2r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r3",
    "Description": "Q7_2r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r4",
    "Description": "Q7_2r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r5",
    "Description": "Q7_2r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r6",
    "Description": "Q7_2r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r7",
    "Description": "Q7_2r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r8",
    "Description": "Q7_2r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r9",
    "Description": "Q7_2r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r10",
    "Description": "Q7_2r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r11",
    "Description": "Q7_2r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_2r12",
    "Description": "Q7_2r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_2"
  },
  {
    "Column": "Q7_3r1",
    "Description": "Q7_3r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r2",
    "Description": "Q7_3r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r3",
    "Description": "Q7_3r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r4",
    "Description": "Q7_3r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r5",
    "Description": "Q7_3r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r6",
    "Description": "Q7_3r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r7",
    "Description": "Q7_3r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r8",
    "Description": "Q7_3r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r9",
    "Description": "Q7_3r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r10",
    "Description": "Q7_3r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r11",
    "Description": "Q7_3r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_3r12",
    "Description": "Q7_3r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_3"
  },
  {
    "Column": "Q7_4r1",
    "Description": "Q7_4r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r2",
    "Description": "Q7_4r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r3",
    "Description": "Q7_4r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r4",
    "Description": "Q7_4r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r5",
    "Description": "Q7_4r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r6",
    "Description": "Q7_4r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r7",
    "Description": "Q7_4r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r8",
    "Description": "Q7_4r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r9",
    "Description": "Q7_4r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r10",
    "Description": "Q7_4r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r11",
    "Description": "Q7_4r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_4r12",
    "Description": "Q7_4r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_4"
  },
  {
    "Column": "Q7_5r1",
    "Description": "Q7_5r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r2",
    "Description": "Q7_5r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r3",
    "Description": "Q7_5r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r4",
    "Description": "Q7_5r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r5",
    "Description": "Q7_5r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r6",
    "Description": "Q7_5r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r7",
    "Description": "Q7_5r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r8",
    "Description": "Q7_5r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r9",
    "Description": "Q7_5r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r10",
    "Description": "Q7_5r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r11",
    "Description": "Q7_5r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_5r12",
    "Description": "Q7_5r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_5"
  },
  {
    "Column": "Q7_6r1",
    "Description": "Q7_6r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r2",
    "Description": "Q7_6r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r3",
    "Description": "Q7_6r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r4",
    "Description": "Q7_6r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r5",
    "Description": "Q7_6r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r6",
    "Description": "Q7_6r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r7",
    "Description": "Q7_6r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r8",
    "Description": "Q7_6r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r9",
    "Description": "Q7_6r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r10",
    "Description": "Q7_6r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r11",
    "Description": "Q7_6r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_6r12",
    "Description": "Q7_6r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_6"
  },
  {
    "Column": "Q7_7r1",
    "Description": "Q7_7r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r2",
    "Description": "Q7_7r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r3",
    "Description": "Q7_7r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r4",
    "Description": "Q7_7r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r5",
    "Description": "Q7_7r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r6",
    "Description": "Q7_7r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r7",
    "Description": "Q7_7r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r8",
    "Description": "Q7_7r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r9",
    "Description": "Q7_7r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r10",
    "Description": "Q7_7r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r11",
    "Description": "Q7_7r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_7r12",
    "Description": "Q7_7r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_7"
  },
  {
    "Column": "Q7_8r1",
    "Description": "Q7_8r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acce",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r2",
    "Description": "Q7_8r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r3",
    "Description": "Q7_8r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r4",
    "Description": "Q7_8r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r5",
    "Description": "Q7_8r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r6",
    "Description": "Q7_8r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r7",
    "Description": "Q7_8r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ rei",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r8",
    "Description": "Q7_8r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r9",
    "Description": "Q7_8r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r10",
    "Description": "Q7_8r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r11",
    "Description": "Q7_8r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account man",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_8r12",
    "Description": "Q7_8r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and any",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_8"
  },
  {
    "Column": "Q7_11r1",
    "Description": "Q7_11r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r2",
    "Description": "Q7_11r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r3",
    "Description": "Q7_11r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r4",
    "Description": "Q7_11r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r5",
    "Description": "Q7_11r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r6",
    "Description": "Q7_11r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r7",
    "Description": "Q7_11r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r8",
    "Description": "Q7_11r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r9",
    "Description": "Q7_11r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r10",
    "Description": "Q7_11r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r11",
    "Description": "Q7_11r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_11r12",
    "Description": "Q7_11r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_11"
  },
  {
    "Column": "Q7_12r1",
    "Description": "Q7_12r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r2",
    "Description": "Q7_12r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r3",
    "Description": "Q7_12r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r4",
    "Description": "Q7_12r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r5",
    "Description": "Q7_12r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r6",
    "Description": "Q7_12r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r7",
    "Description": "Q7_12r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r8",
    "Description": "Q7_12r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r9",
    "Description": "Q7_12r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r10",
    "Description": "Q7_12r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r11",
    "Description": "Q7_12r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_12r12",
    "Description": "Q7_12r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_12"
  },
  {
    "Column": "Q7_13r1",
    "Description": "Q7_13r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r2",
    "Description": "Q7_13r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r3",
    "Description": "Q7_13r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r4",
    "Description": "Q7_13r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r5",
    "Description": "Q7_13r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r6",
    "Description": "Q7_13r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r7",
    "Description": "Q7_13r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r8",
    "Description": "Q7_13r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r9",
    "Description": "Q7_13r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r10",
    "Description": "Q7_13r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r11",
    "Description": "Q7_13r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_13r12",
    "Description": "Q7_13r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_13"
  },
  {
    "Column": "Q7_14r1",
    "Description": "Q7_14r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r2",
    "Description": "Q7_14r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r3",
    "Description": "Q7_14r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r4",
    "Description": "Q7_14r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r5",
    "Description": "Q7_14r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r6",
    "Description": "Q7_14r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r7",
    "Description": "Q7_14r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r8",
    "Description": "Q7_14r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r9",
    "Description": "Q7_14r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r10",
    "Description": "Q7_14r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r11",
    "Description": "Q7_14r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_14r12",
    "Description": "Q7_14r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_14"
  },
  {
    "Column": "Q7_15r1",
    "Description": "Q7_15r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r2",
    "Description": "Q7_15r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r3",
    "Description": "Q7_15r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r4",
    "Description": "Q7_15r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r5",
    "Description": "Q7_15r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r6",
    "Description": "Q7_15r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r7",
    "Description": "Q7_15r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r8",
    "Description": "Q7_15r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r9",
    "Description": "Q7_15r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r10",
    "Description": "Q7_15r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r11",
    "Description": "Q7_15r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_15r12",
    "Description": "Q7_15r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_15"
  },
  {
    "Column": "Q7_16r1",
    "Description": "Q7_16r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r2",
    "Description": "Q7_16r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r3",
    "Description": "Q7_16r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r4",
    "Description": "Q7_16r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r5",
    "Description": "Q7_16r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r6",
    "Description": "Q7_16r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r7",
    "Description": "Q7_16r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r8",
    "Description": "Q7_16r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r9",
    "Description": "Q7_16r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r10",
    "Description": "Q7_16r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r11",
    "Description": "Q7_16r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_16r12",
    "Description": "Q7_16r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_16"
  },
  {
    "Column": "Q7_17r1",
    "Description": "Q7_17r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r2",
    "Description": "Q7_17r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r3",
    "Description": "Q7_17r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r4",
    "Description": "Q7_17r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r5",
    "Description": "Q7_17r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r6",
    "Description": "Q7_17r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r7",
    "Description": "Q7_17r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r8",
    "Description": "Q7_17r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r9",
    "Description": "Q7_17r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r10",
    "Description": "Q7_17r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r11",
    "Description": "Q7_17r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_17r12",
    "Description": "Q7_17r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_17"
  },
  {
    "Column": "Q7_18r1",
    "Description": "Q7_18r1: Have a presence in my practice / regular touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, acc",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r2",
    "Description": "Q7_18r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r3",
    "Description": "Q7_18r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r4",
    "Description": "Q7_18r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r5",
    "Description": "Q7_18r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r6",
    "Description": "Q7_18r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r7",
    "Description": "Q7_18r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ re",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r8",
    "Description": "Q7_18r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, ac",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r9",
    "Description": "Q7_18r9: Provides information that is helpful in making my treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r10",
    "Description": "Q7_18r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, a",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r11",
    "Description": "Q7_18r11: Tailors interactions and information delivery to my individual needs - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account ma",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q7_18r12",
    "Description": "Q7_18r12: Respects my time - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers, and an",
    "Answer_Options": "1=1 - Does Not Describe at all,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Describes Completely",
    "ParentQuestion": "Q7_18"
  },
  {
    "Column": "Q8r1",
    "Description": "Q8r1: Astellas - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r2",
    "Description": "Q8r2: EMD Serono - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r3",
    "Description": "Q8r3: Bristol-Myers Squibb (BMS) - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r4",
    "Description": "Q8r4: Genentech - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r5",
    "Description": "Q8r5: Pfizer - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r6",
    "Description": "Q8r6: Janssen / Johnson & Johnson - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r7",
    "Description": "Q8r7: Bayer - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r8",
    "Description": "Q8r8: Abbvie - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r11",
    "Description": "Q8r11: Novartis - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r12",
    "Description": "Q8r12: Daiichi-Sankyo - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r13",
    "Description": "Q8r13: Amgen - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r14",
    "Description": "Q8r14: Seagen (Seattle Genetics) - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r15",
    "Description": "Q8r15: GSK - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r16",
    "Description": "Q8r16: AstraZeneca - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r17",
    "Description": "Q8r17: Gilead - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q8r18",
    "Description": "Q8r18: Merck - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q8"
  },
  {
    "Column": "Q9",
    "Description": "Q9: Which pharmaceutical company do you consider to be the best in terms of your overall experiences with them specifically related to oncology?",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck,19=Other (Specify):"
  },
  {
    "Column": "Q9r19oe",
    "Description": "Q9r19oe: Which pharmaceutical company do you consider to be the best in terms of your overall experiences with them specifically related to oncology? - Other (Specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9",
    "Context": "Q9: Q9: Which pharmaceutical company do you consider to be the best in terms of your overall experiences with them specifically related to oncology?"
  },
  {
    "Column": "Q9a_H",
    "Description": "Q9a_H: And, which do you consider to be the best in terms of your overall experiences specifically related to AML?",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck,19=Other (Specify):"
  },
  {
    "Column": "Q9a_Hr19oe",
    "Description": "Q9a_Hr19oe: And, which do you consider to be the best in terms of your overall experiences specifically related to AML? - Other (Specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9a_H",
    "Context": "Q9a_H: Q9a_H: And, which do you consider to be the best in terms of your overall experiences specifically related to AML?"
  },
  {
    "Column": "Q9a_OU",
    "Description": "Q9a_OU: And, which do you consider to be the best in terms of your overall experiences specifically related to prostate cancer?",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck,19=Other (Specify):"
  },
  {
    "Column": "Q9a_OUr19oe",
    "Description": "Q9a_OUr19oe: And, which do you consider to be the best in terms of your overall experiences specifically related to prostate cancer? - Other (Specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9a_OU",
    "Context": "Q9a_OU: Q9a_OU: And, which do you consider to be the best in terms of your overall experiences specifically related to prostate cancer?"
  },
  {
    "Column": "Q9aOB",
    "Description": "Q9aOB: And, which do you consider to be the best in terms of your overall experiences specifically related to bladder cancer?",
    "Answer_Options": "1=Astellas,2=EMD Serono,3=Bristol-Myers Squibb (BMS),4=Genentech,5=Pfizer,6=Janssen / Johnson & Johnson,7=Bayer,8=Abbvie,11=Novartis,12=Daiichi-Sankyo,13=Amgen,14=Seagen (Seattle Genetics),15=GSK,16=AstraZeneca,17=Gilead,18=Merck,19=Other (Specify):"
  },
  {
    "Column": "Q9aOBr19oe",
    "Description": "Q9aOBr19oe: And, which do you consider to be the best in terms of your overall experiences specifically related to bladder cancer? - Other (Specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9aOB",
    "Context": "Q9aOB: Q9aOB: And, which do you consider to be the best in terms of your overall experiences specifically related to bladder cancer?"
  },
  {
    "Column": "Q9b",
    "Description": "Q9b: Why do you consider [pipe:Q9] the best in terms of your overall experiences specifically related to oncology?",
    "Answer_Options": "NA"
  },
  {
    "Column": "Q9cc1",
    "Description": "Q9cc1: Astellas - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc2",
    "Description": "Q9cc2: EMD Serono - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc3",
    "Description": "Q9cc3: Bristol-Myers Squibb (BMS) - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc4",
    "Description": "Q9cc4: Genentech - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc5",
    "Description": "Q9cc5: Pfizer - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc6",
    "Description": "Q9cc6: Janssen / Johnson & Johnson - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc7",
    "Description": "Q9cc7: Bayer - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc8",
    "Description": "Q9cc8: Abbvie - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc11",
    "Description": "Q9cc11: Novartis - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc12",
    "Description": "Q9cc12: Daiichi-Sankyo - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc13",
    "Description": "Q9cc13: Amgen - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc14",
    "Description": "Q9cc14: Seagen (Seattle Genetics) - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc15",
    "Description": "Q9cc15: GSK - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc16",
    "Description": "Q9cc16: AstraZeneca - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc17",
    "Description": "Q9cc17: Gilead - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cc18",
    "Description": "Q9cc18: Merck - For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs.",
    "Answer_Options": "1=In-person discussion (i.e. at practice setting),2=Telephone call,3=Email communication,4=Conference discussion (e.g. virtual or live booth visit, meeting),5=Website / Online portal,6=Other type of interaction (Specify):,7=Unsure / I don't remember,8=Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage),9=Social media",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9cr6oe",
    "Description": "Q9cr6oe: For each company below, please indicate the MOST RECENT type of interaction / encounter you have had with them related to their oncology drugs. - Other type of interaction (Specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9c"
  },
  {
    "Column": "Q9dc1",
    "Description": "Q9dc1: Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc2",
    "Description": "Q9dc2: EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc3",
    "Description": "Q9dc3: Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc4",
    "Description": "Q9dc4: Genentech - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc5",
    "Description": "Q9dc5: Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc6",
    "Description": "Q9dc6: Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc7",
    "Description": "Q9dc7: Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc8",
    "Description": "Q9dc8: Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc11",
    "Description": "Q9dc11: Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc12",
    "Description": "Q9dc12: Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc13",
    "Description": "Q9dc13: Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc14",
    "Description": "Q9dc14: Seagen (Seattle Genetics) - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc15",
    "Description": "Q9dc15: GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc16",
    "Description": "Q9dc16: AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc17",
    "Description": "Q9dc17: Gilead - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dc18",
    "Description": "Q9dc18: Merck - For this MOST RECENT interaction, what type of personnel did you interact with?",
    "Answer_Options": "1=Product sales representative,2=Medical science liaison (MSL) (i.e., medical affairs personnel whose main responsibility is interacting with healthcare,3=Other company employee (e.g., reimbursement hub representative, phone representative in corporate department, etc.),4=Other type of person (Specify):,5=Did not directly interact with personnel,6=Unsure / I don't remember,8=Account manager (i.e., pharmaceutical company professionals that support your organization on more strategic issues but,9=Access / reimbursement manager (i.e., personnel who specializes in providing support for patient access/reimbursement)",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9dr4oe",
    "Description": "Q9dr4oe: For this MOST RECENT interaction, what type of personnel did you interact with? - Other type of person (Specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9d"
  },
  {
    "Column": "Q9er1",
    "Description": "Q9er1: Astellas - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er2",
    "Description": "Q9er2: EMD Serono - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er3",
    "Description": "Q9er3: Bristol-Myers Squibb (BMS) - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er4",
    "Description": "Q9er4: Genentech - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er5",
    "Description": "Q9er5: Pfizer - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er6",
    "Description": "Q9er6: Janssen / Johnson & Johnson - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er7",
    "Description": "Q9er7: Bayer - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er8",
    "Description": "Q9er8: Abbvie - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er11",
    "Description": "Q9er11: Novartis - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er12",
    "Description": "Q9er12: Daiichi-Sankyo - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er13",
    "Description": "Q9er13: Amgen - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er14",
    "Description": "Q9er14: Seagen (Seattle Genetics) - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er15",
    "Description": "Q9er15: GSK - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er16",
    "Description": "Q9er16: AstraZeneca - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er17",
    "Description": "Q9er17: Gilead - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9er18",
    "Description": "Q9er18: Merck - How satisfied were you with the MOST RECENT interaction?",
    "Answer_Options": "1=1 - Not at all Satisfied,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely Satisfied",
    "ParentQuestion": "Q9e"
  },
  {
    "Column": "Q9fr1",
    "Description": "Q9fr1: Astellas - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr2",
    "Description": "Q9fr2: EMD Serono - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr3",
    "Description": "Q9fr3: Bristol-Myers Squibb (BMS) - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr4",
    "Description": "Q9fr4: Genentech - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr5",
    "Description": "Q9fr5: Pfizer - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr6",
    "Description": "Q9fr6: Janssen / Johnson & Johnson - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr7",
    "Description": "Q9fr7: Bayer - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr8",
    "Description": "Q9fr8: Abbvie - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr11",
    "Description": "Q9fr11: Novartis - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr12",
    "Description": "Q9fr12: Daiichi-Sankyo - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr13",
    "Description": "Q9fr13: Amgen - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr14",
    "Description": "Q9fr14: Seagen (Seattle Genetics) - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr15",
    "Description": "Q9fr15: GSK - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr16",
    "Description": "Q9fr16: AstraZeneca - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr17",
    "Description": "Q9fr17: Gilead - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9fr18",
    "Description": "Q9fr18: Merck - [pipe:pipe_Q9f]",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9f"
  },
  {
    "Column": "Q9Ir1c1",
    "Description": "Q9Ir1c1: Astellas - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c2",
    "Description": "Q9Ir1c2: EMD Serono - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c3",
    "Description": "Q9Ir1c3: Bristol-Myers Squibb (BMS) - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c4",
    "Description": "Q9Ir1c4: Genentech - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c5",
    "Description": "Q9Ir1c5: Pfizer - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c6",
    "Description": "Q9Ir1c6: Janssen / Johnson & Johnson - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c7",
    "Description": "Q9Ir1c7: Bayer - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c8",
    "Description": "Q9Ir1c8: Abbvie - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c11",
    "Description": "Q9Ir1c11: Novartis - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c12",
    "Description": "Q9Ir1c12: Daiichi-Sankyo - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c13",
    "Description": "Q9Ir1c13: Amgen - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c14",
    "Description": "Q9Ir1c14: Seagen (Seattle Genetics) - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c15",
    "Description": "Q9Ir1c15: GSK - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c16",
    "Description": "Q9Ir1c16: AstraZeneca - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c17",
    "Description": "Q9Ir1c17: Gilead - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir1c18",
    "Description": "Q9Ir1c18: Merck - 1 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c1",
    "Description": "Q9Ir2c1: Astellas - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c2",
    "Description": "Q9Ir2c2: EMD Serono - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c3",
    "Description": "Q9Ir2c3: Bristol-Myers Squibb (BMS) - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c4",
    "Description": "Q9Ir2c4: Genentech - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c5",
    "Description": "Q9Ir2c5: Pfizer - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c6",
    "Description": "Q9Ir2c6: Janssen / Johnson & Johnson - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c7",
    "Description": "Q9Ir2c7: Bayer - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c8",
    "Description": "Q9Ir2c8: Abbvie - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c11",
    "Description": "Q9Ir2c11: Novartis - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c12",
    "Description": "Q9Ir2c12: Daiichi-Sankyo - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c13",
    "Description": "Q9Ir2c13: Amgen - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c14",
    "Description": "Q9Ir2c14: Seagen (Seattle Genetics) - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c15",
    "Description": "Q9Ir2c15: GSK - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c16",
    "Description": "Q9Ir2c16: AstraZeneca - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c17",
    "Description": "Q9Ir2c17: Gilead - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir2c18",
    "Description": "Q9Ir2c18: Merck - 2 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c1",
    "Description": "Q9Ir3c1: Astellas - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c2",
    "Description": "Q9Ir3c2: EMD Serono - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c3",
    "Description": "Q9Ir3c3: Bristol-Myers Squibb (BMS) - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c4",
    "Description": "Q9Ir3c4: Genentech - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c5",
    "Description": "Q9Ir3c5: Pfizer - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c6",
    "Description": "Q9Ir3c6: Janssen / Johnson & Johnson - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c7",
    "Description": "Q9Ir3c7: Bayer - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c8",
    "Description": "Q9Ir3c8: Abbvie - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c11",
    "Description": "Q9Ir3c11: Novartis - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c12",
    "Description": "Q9Ir3c12: Daiichi-Sankyo - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c13",
    "Description": "Q9Ir3c13: Amgen - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c14",
    "Description": "Q9Ir3c14: Seagen (Seattle Genetics) - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c15",
    "Description": "Q9Ir3c15: GSK - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c16",
    "Description": "Q9Ir3c16: AstraZeneca - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c17",
    "Description": "Q9Ir3c17: Gilead - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir3c18",
    "Description": "Q9Ir3c18: Merck - 3 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c1",
    "Description": "Q9Ir4c1: Astellas - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c2",
    "Description": "Q9Ir4c2: EMD Serono - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c3",
    "Description": "Q9Ir4c3: Bristol-Myers Squibb (BMS) - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c4",
    "Description": "Q9Ir4c4: Genentech - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c5",
    "Description": "Q9Ir4c5: Pfizer - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c6",
    "Description": "Q9Ir4c6: Janssen / Johnson & Johnson - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c7",
    "Description": "Q9Ir4c7: Bayer - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c8",
    "Description": "Q9Ir4c8: Abbvie - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c11",
    "Description": "Q9Ir4c11: Novartis - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c12",
    "Description": "Q9Ir4c12: Daiichi-Sankyo - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c13",
    "Description": "Q9Ir4c13: Amgen - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c14",
    "Description": "Q9Ir4c14: Seagen (Seattle Genetics) - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c15",
    "Description": "Q9Ir4c15: GSK - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c16",
    "Description": "Q9Ir4c16: AstraZeneca - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c17",
    "Description": "Q9Ir4c17: Gilead - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir4c18",
    "Description": "Q9Ir4c18: Merck - 4 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c1",
    "Description": "Q9Ir5c1: Astellas - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c2",
    "Description": "Q9Ir5c2: EMD Serono - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c3",
    "Description": "Q9Ir5c3: Bristol-Myers Squibb (BMS) - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c4",
    "Description": "Q9Ir5c4: Genentech - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c5",
    "Description": "Q9Ir5c5: Pfizer - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c6",
    "Description": "Q9Ir5c6: Janssen / Johnson & Johnson - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c7",
    "Description": "Q9Ir5c7: Bayer - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c8",
    "Description": "Q9Ir5c8: Abbvie - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c11",
    "Description": "Q9Ir5c11: Novartis - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c12",
    "Description": "Q9Ir5c12: Daiichi-Sankyo - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c13",
    "Description": "Q9Ir5c13: Amgen - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c14",
    "Description": "Q9Ir5c14: Seagen (Seattle Genetics) - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c15",
    "Description": "Q9Ir5c15: GSK - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c16",
    "Description": "Q9Ir5c16: AstraZeneca - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c17",
    "Description": "Q9Ir5c17: Gilead - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir5c18",
    "Description": "Q9Ir5c18: Merck - 5 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c1",
    "Description": "Q9Ir6c1: Astellas - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c2",
    "Description": "Q9Ir6c2: EMD Serono - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c3",
    "Description": "Q9Ir6c3: Bristol-Myers Squibb (BMS) - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c4",
    "Description": "Q9Ir6c4: Genentech - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c5",
    "Description": "Q9Ir6c5: Pfizer - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c6",
    "Description": "Q9Ir6c6: Janssen / Johnson & Johnson - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c7",
    "Description": "Q9Ir6c7: Bayer - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c8",
    "Description": "Q9Ir6c8: Abbvie - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c11",
    "Description": "Q9Ir6c11: Novartis - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c12",
    "Description": "Q9Ir6c12: Daiichi-Sankyo - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c13",
    "Description": "Q9Ir6c13: Amgen - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c14",
    "Description": "Q9Ir6c14: Seagen (Seattle Genetics) - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c15",
    "Description": "Q9Ir6c15: GSK - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c16",
    "Description": "Q9Ir6c16: AstraZeneca - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c17",
    "Description": "Q9Ir6c17: Gilead - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir6c18",
    "Description": "Q9Ir6c18: Merck - 6 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c1",
    "Description": "Q9Ir7c1: Astellas - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c2",
    "Description": "Q9Ir7c2: EMD Serono - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c3",
    "Description": "Q9Ir7c3: Bristol-Myers Squibb (BMS) - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c4",
    "Description": "Q9Ir7c4: Genentech - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c5",
    "Description": "Q9Ir7c5: Pfizer - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c6",
    "Description": "Q9Ir7c6: Janssen / Johnson & Johnson - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c7",
    "Description": "Q9Ir7c7: Bayer - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c8",
    "Description": "Q9Ir7c8: Abbvie - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c11",
    "Description": "Q9Ir7c11: Novartis - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c12",
    "Description": "Q9Ir7c12: Daiichi-Sankyo - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c13",
    "Description": "Q9Ir7c13: Amgen - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c14",
    "Description": "Q9Ir7c14: Seagen (Seattle Genetics) - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c15",
    "Description": "Q9Ir7c15: GSK - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c16",
    "Description": "Q9Ir7c16: AstraZeneca - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c17",
    "Description": "Q9Ir7c17: Gilead - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir7c18",
    "Description": "Q9Ir7c18: Merck - 7 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c1",
    "Description": "Q9Ir8c1: Astellas - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c2",
    "Description": "Q9Ir8c2: EMD Serono - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c3",
    "Description": "Q9Ir8c3: Bristol-Myers Squibb (BMS) - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c4",
    "Description": "Q9Ir8c4: Genentech - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c5",
    "Description": "Q9Ir8c5: Pfizer - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c6",
    "Description": "Q9Ir8c6: Janssen / Johnson & Johnson - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c7",
    "Description": "Q9Ir8c7: Bayer - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c8",
    "Description": "Q9Ir8c8: Abbvie - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c11",
    "Description": "Q9Ir8c11: Novartis - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c12",
    "Description": "Q9Ir8c12: Daiichi-Sankyo - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c13",
    "Description": "Q9Ir8c13: Amgen - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c14",
    "Description": "Q9Ir8c14: Seagen (Seattle Genetics) - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c15",
    "Description": "Q9Ir8c15: GSK - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c16",
    "Description": "Q9Ir8c16: AstraZeneca - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c17",
    "Description": "Q9Ir8c17: Gilead - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir8c18",
    "Description": "Q9Ir8c18: Merck - 8 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c1",
    "Description": "Q9Ir9c1: Astellas - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c2",
    "Description": "Q9Ir9c2: EMD Serono - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c3",
    "Description": "Q9Ir9c3: Bristol-Myers Squibb (BMS) - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c4",
    "Description": "Q9Ir9c4: Genentech - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c5",
    "Description": "Q9Ir9c5: Pfizer - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c6",
    "Description": "Q9Ir9c6: Janssen / Johnson & Johnson - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c7",
    "Description": "Q9Ir9c7: Bayer - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c8",
    "Description": "Q9Ir9c8: Abbvie - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c11",
    "Description": "Q9Ir9c11: Novartis - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c12",
    "Description": "Q9Ir9c12: Daiichi-Sankyo - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c13",
    "Description": "Q9Ir9c13: Amgen - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c14",
    "Description": "Q9Ir9c14: Seagen (Seattle Genetics) - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c15",
    "Description": "Q9Ir9c15: GSK - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c16",
    "Description": "Q9Ir9c16: AstraZeneca - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c17",
    "Description": "Q9Ir9c17: Gilead - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir9c18",
    "Description": "Q9Ir9c18: Merck - 9 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c1",
    "Description": "Q9Ir10c1: Astellas - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c2",
    "Description": "Q9Ir10c2: EMD Serono - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c3",
    "Description": "Q9Ir10c3: Bristol-Myers Squibb (BMS) - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c4",
    "Description": "Q9Ir10c4: Genentech - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c5",
    "Description": "Q9Ir10c5: Pfizer - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c6",
    "Description": "Q9Ir10c6: Janssen / Johnson & Johnson - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c7",
    "Description": "Q9Ir10c7: Bayer - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c8",
    "Description": "Q9Ir10c8: Abbvie - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c11",
    "Description": "Q9Ir10c11: Novartis - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c12",
    "Description": "Q9Ir10c12: Daiichi-Sankyo - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c13",
    "Description": "Q9Ir10c13: Amgen - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c14",
    "Description": "Q9Ir10c14: Seagen (Seattle Genetics) - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c15",
    "Description": "Q9Ir10c15: GSK - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c16",
    "Description": "Q9Ir10c16: AstraZeneca - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c17",
    "Description": "Q9Ir10c17: Gilead - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir10c18",
    "Description": "Q9Ir10c18: Merck - 10 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c1",
    "Description": "Q9Ir11c1: Astellas - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c2",
    "Description": "Q9Ir11c2: EMD Serono - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c3",
    "Description": "Q9Ir11c3: Bristol-Myers Squibb (BMS) - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c4",
    "Description": "Q9Ir11c4: Genentech - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c5",
    "Description": "Q9Ir11c5: Pfizer - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c6",
    "Description": "Q9Ir11c6: Janssen / Johnson & Johnson - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c7",
    "Description": "Q9Ir11c7: Bayer - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c8",
    "Description": "Q9Ir11c8: Abbvie - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c11",
    "Description": "Q9Ir11c11: Novartis - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c12",
    "Description": "Q9Ir11c12: Daiichi-Sankyo - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c13",
    "Description": "Q9Ir11c13: Amgen - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c14",
    "Description": "Q9Ir11c14: Seagen (Seattle Genetics) - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c15",
    "Description": "Q9Ir11c15: GSK - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c16",
    "Description": "Q9Ir11c16: AstraZeneca - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c17",
    "Description": "Q9Ir11c17: Gilead - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir11c18",
    "Description": "Q9Ir11c18: Merck - 11 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c1",
    "Description": "Q9Ir12c1: Astellas - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c2",
    "Description": "Q9Ir12c2: EMD Serono - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c3",
    "Description": "Q9Ir12c3: Bristol-Myers Squibb (BMS) - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c4",
    "Description": "Q9Ir12c4: Genentech - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c5",
    "Description": "Q9Ir12c5: Pfizer - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c6",
    "Description": "Q9Ir12c6: Janssen / Johnson & Johnson - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c7",
    "Description": "Q9Ir12c7: Bayer - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c8",
    "Description": "Q9Ir12c8: Abbvie - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c11",
    "Description": "Q9Ir12c11: Novartis - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c12",
    "Description": "Q9Ir12c12: Daiichi-Sankyo - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c13",
    "Description": "Q9Ir12c13: Amgen - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c14",
    "Description": "Q9Ir12c14: Seagen (Seattle Genetics) - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c15",
    "Description": "Q9Ir12c15: GSK - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c16",
    "Description": "Q9Ir12c16: AstraZeneca - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c17",
    "Description": "Q9Ir12c17: Gilead - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir12c18",
    "Description": "Q9Ir12c18: Merck - 12 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c1",
    "Description": "Q9Ir13c1: Astellas - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c2",
    "Description": "Q9Ir13c2: EMD Serono - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c3",
    "Description": "Q9Ir13c3: Bristol-Myers Squibb (BMS) - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c4",
    "Description": "Q9Ir13c4: Genentech - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c5",
    "Description": "Q9Ir13c5: Pfizer - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c6",
    "Description": "Q9Ir13c6: Janssen / Johnson & Johnson - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c7",
    "Description": "Q9Ir13c7: Bayer - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c8",
    "Description": "Q9Ir13c8: Abbvie - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c11",
    "Description": "Q9Ir13c11: Novartis - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c12",
    "Description": "Q9Ir13c12: Daiichi-Sankyo - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c13",
    "Description": "Q9Ir13c13: Amgen - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c14",
    "Description": "Q9Ir13c14: Seagen (Seattle Genetics) - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c15",
    "Description": "Q9Ir13c15: GSK - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c16",
    "Description": "Q9Ir13c16: AstraZeneca - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c17",
    "Description": "Q9Ir13c17: Gilead - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir13c18",
    "Description": "Q9Ir13c18: Merck - 13 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c1",
    "Description": "Q9Ir14c1: Astellas - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c2",
    "Description": "Q9Ir14c2: EMD Serono - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c3",
    "Description": "Q9Ir14c3: Bristol-Myers Squibb (BMS) - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c4",
    "Description": "Q9Ir14c4: Genentech - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c5",
    "Description": "Q9Ir14c5: Pfizer - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c6",
    "Description": "Q9Ir14c6: Janssen / Johnson & Johnson - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c7",
    "Description": "Q9Ir14c7: Bayer - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c8",
    "Description": "Q9Ir14c8: Abbvie - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c11",
    "Description": "Q9Ir14c11: Novartis - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c12",
    "Description": "Q9Ir14c12: Daiichi-Sankyo - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c13",
    "Description": "Q9Ir14c13: Amgen - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c14",
    "Description": "Q9Ir14c14: Seagen (Seattle Genetics) - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c15",
    "Description": "Q9Ir14c15: GSK - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c16",
    "Description": "Q9Ir14c16: AstraZeneca - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c17",
    "Description": "Q9Ir14c17: Gilead - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir14c18",
    "Description": "Q9Ir14c18: Merck - 14 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c1",
    "Description": "Q9Ir15c1: Astellas - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c2",
    "Description": "Q9Ir15c2: EMD Serono - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c3",
    "Description": "Q9Ir15c3: Bristol-Myers Squibb (BMS) - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c4",
    "Description": "Q9Ir15c4: Genentech - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c5",
    "Description": "Q9Ir15c5: Pfizer - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c6",
    "Description": "Q9Ir15c6: Janssen / Johnson & Johnson - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c7",
    "Description": "Q9Ir15c7: Bayer - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c8",
    "Description": "Q9Ir15c8: Abbvie - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c11",
    "Description": "Q9Ir15c11: Novartis - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c12",
    "Description": "Q9Ir15c12: Daiichi-Sankyo - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c13",
    "Description": "Q9Ir15c13: Amgen - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c14",
    "Description": "Q9Ir15c14: Seagen (Seattle Genetics) - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c15",
    "Description": "Q9Ir15c15: GSK - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c16",
    "Description": "Q9Ir15c16: AstraZeneca - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c17",
    "Description": "Q9Ir15c17: Gilead - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9Ir15c18",
    "Description": "Q9Ir15c18: Merck - 15 - Please indicate which oncology medications you associate with each of the following companies.Please list ALL oncology medications you are aware of from each manufacturer.",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9I"
  },
  {
    "Column": "Q9gc1",
    "Description": "Q9gc1: Astellas - In the past 6 months, do you recall seeing advertising for the following companies related to their oncology portfolio?Please think about the advertising for the oncology portfolio overall, NOT advertising for a specific drug in the port",
    "Answer_Options": "1=Yes,2=No,3=Unsure",
    "ParentQuestion": "Q9g"
  },
  {
    "Column": "Q9gc2",
    "Description": "Q9gc2: Genentech - In the past 6 months, do you recall seeing advertising for the following companies related to their oncology portfolio?Please think about the advertising for the oncology portfolio overall, NOT advertising for a specific drug in the por",
    "Answer_Options": "1=Yes,2=No,3=Unsure",
    "ParentQuestion": "Q9g"
  },
  {
    "Column": "Q9gc3",
    "Description": "Q9gc3: BMS - In the past 6 months, do you recall seeing advertising for the following companies related to their oncology portfolio?Please think about the advertising for the oncology portfolio overall, NOT advertising for a specific drug in the portfolio",
    "Answer_Options": "1=Yes,2=No,3=Unsure",
    "ParentQuestion": "Q9g"
  },
  {
    "Column": "Q9gac1",
    "Description": "Q9gac1: $ {res.Astellas_ad_img_link} - In the past 6 months, do you recall seeing the following advertisements?",
    "Answer_Options": "1=Yes,2=No,3=Unsure",
    "ParentQuestion": "Q9ga"
  },
  {
    "Column": "Q9gac2",
    "Description": "Q9gac2: $ {res.Genetech_Ad_img_link} - In the past 6 months, do you recall seeing the following advertisements?",
    "Answer_Options": "1=Yes,2=No,3=Unsure",
    "ParentQuestion": "Q9ga"
  },
  {
    "Column": "Q9gac3",
    "Description": "Q9gac3: $ {res.BMS_Ad_img_link} - In the past 6 months, do you recall seeing the following advertisements?",
    "Answer_Options": "1=Yes,2=No,3=Unsure",
    "ParentQuestion": "Q9ga"
  },
  {
    "Column": "Q9h_1r1",
    "Description": "Q9h_1r1: Informational email from this drug company - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Informational email from this drug company,1=Informational email from this drug company",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r2",
    "Description": "Q9h_1r2: Information you viewed on the drug company website - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Information you viewed on the drug company website,1=Information you viewed on the drug company website",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r4",
    "Description": "Q9h_1r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Medical journals / publications in print,1=Medical journals / publications in print",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r5",
    "Description": "Q9h_1r5: Medical journals / publications online - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Medical journals / publications online,1=Medical journals / publications online",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r6",
    "Description": "Q9h_1r6: Online (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Online (e.g., Medscape, Bulletin Healthcare),1=Online (e.g., Medscape, Bulletin Healthcare)",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r9",
    "Description": "Q9h_1r9: Conference / trade show - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Conference / trade show,1=Conference / trade show",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r10",
    "Description": "Q9h_1r10: Other (please specify): - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Other (please specify):,1=Other (please specify):",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r11",
    "Description": "Q9h_1r11: Don’t recall - In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Don’t recall,1=Don’t recall",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_1r10oe",
    "Description": "Q9h_1r10oe: In the past 6 months, where do you recall seeing the following advertising for Astellas related to their oncology portfolio? - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9h_1"
  },
  {
    "Column": "Q9h_2r1",
    "Description": "Q9h_2r1: Informational email from this drug company - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Informational email from this drug company,1=Informational email from this drug company",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r2",
    "Description": "Q9h_2r2: Information you viewed on the drug company website - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Information you viewed on the drug company website,1=Information you viewed on the drug company website",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r4",
    "Description": "Q9h_2r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Medical journals / publications in print,1=Medical journals / publications in print",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r5",
    "Description": "Q9h_2r5: Medical journals / publications online - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Medical journals / publications online,1=Medical journals / publications online",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r6",
    "Description": "Q9h_2r6: Online (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Online (e.g., Medscape, Bulletin Healthcare),1=Online (e.g., Medscape, Bulletin Healthcare)",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r9",
    "Description": "Q9h_2r9: Conference / trade show - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Conference / trade show,1=Conference / trade show",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r10",
    "Description": "Q9h_2r10: Other (please specify): - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Other (please specify):,1=Other (please specify):",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r11",
    "Description": "Q9h_2r11: Don’t recall - In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Don’t recall,1=Don’t recall",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_2r10oe",
    "Description": "Q9h_2r10oe: In the past 6 months, where do you recall seeing the following advertising for Genentech related to their oncology portfolio? - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9h_2"
  },
  {
    "Column": "Q9h_3r1",
    "Description": "Q9h_3r1: Informational email from this drug company - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Informational email from this drug company,1=Informational email from this drug company",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r2",
    "Description": "Q9h_3r2: Information you viewed on the drug company website - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Information you viewed on the drug company website,1=Information you viewed on the drug company website",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r4",
    "Description": "Q9h_3r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Medical journals / publications in print,1=Medical journals / publications in print",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r5",
    "Description": "Q9h_3r5: Medical journals / publications online - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Medical journals / publications online,1=Medical journals / publications online",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r6",
    "Description": "Q9h_3r6: Online (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Online (e.g., Medscape, Bulletin Healthcare),1=Online (e.g., Medscape, Bulletin Healthcare)",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r9",
    "Description": "Q9h_3r9: Conference / trade show - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Conference / trade show,1=Conference / trade show",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r10",
    "Description": "Q9h_3r10: Other (please specify): - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Other (please specify):,1=Other (please specify):",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r11",
    "Description": "Q9h_3r11: Don’t recall - In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio?",
    "Answer_Options": "0=NO TO: Don’t recall,1=Don’t recall",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9h_3r10oe",
    "Description": "Q9h_3r10oe: In the past 6 months, where do you recall seeing the following advertising for BMS related to their oncology portfolio? - Other (please specify):",
    "Answer_Options": "NA",
    "ParentQuestion": "Q9h_3"
  },
  {
    "Column": "Q9j_1r1",
    "Description": "Q9j_1r1: Unique & differentiating - Now please rate the performance of each advertisement on the following metrics. Astellas",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_1"
  },
  {
    "Column": "Q9j_1r2",
    "Description": "Q9j_1r2: Clear communication of message - Now please rate the performance of each advertisement on the following metrics. Astellas",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_1"
  },
  {
    "Column": "Q9j_1r3",
    "Description": "Q9j_1r3: Motivates me to find out more about this company’s oncology portfolio - Now please rate the performance of each advertisement on the following metrics. Astellas",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_1"
  },
  {
    "Column": "Q9j_1r4",
    "Description": "Q9j_1r4: Appropriate for a drug company with an oncology portfolio - Now please rate the performance of each advertisement on the following metrics. Astellas",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_1"
  },
  {
    "Column": "Q9j_2r1",
    "Description": "Q9j_2r1: Unique & differentiating - Now please rate the performance of each advertisement on the following metrics. Genentech",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_2"
  },
  {
    "Column": "Q9j_2r2",
    "Description": "Q9j_2r2: Clear communication of message - Now please rate the performance of each advertisement on the following metrics. Genentech",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_2"
  },
  {
    "Column": "Q9j_2r3",
    "Description": "Q9j_2r3: Motivates me to find out more about this company’s oncology portfolio - Now please rate the performance of each advertisement on the following metrics. Genentech",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_2"
  },
  {
    "Column": "Q9j_2r4",
    "Description": "Q9j_2r4: Appropriate for a drug company with an oncology portfolio - Now please rate the performance of each advertisement on the following metrics. Genentech",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_2"
  },
  {
    "Column": "Q9j_3r1",
    "Description": "Q9j_3r1: Unique & differentiating - Now please rate the performance of each advertisement on the following metrics. BMS",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_3"
  },
  {
    "Column": "Q9j_3r2",
    "Description": "Q9j_3r2: Clear communication of message - Now please rate the performance of each advertisement on the following metrics. BMS",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_3"
  },
  {
    "Column": "Q9j_3r3",
    "Description": "Q9j_3r3: Motivates me to find out more about this company’s oncology portfolio - Now please rate the performance of each advertisement on the following metrics. BMS",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_3"
  },
  {
    "Column": "Q9j_3r4",
    "Description": "Q9j_3r4: Appropriate for a drug company with an oncology portfolio - Now please rate the performance of each advertisement on the following metrics. BMS",
    "Answer_Options": "1=1 - Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Performs extremely well",
    "ParentQuestion": "Q9j_3"
  },
  {
    "Column": "Q10r1",
    "Description": "Q10r1: The rep showed me print materials - Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of the following approaches?",
    "Answer_Options": "1=All/most of the time,2=Some of the time,3=Never",
    "ParentQuestion": "Q10"
  },
  {
    "Column": "Q10r2",
    "Description": "Q10r2: The rep showed me the information on his/her iPad - Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of the following approaches?",
    "Answer_Options": "1=All/most of the time,2=Some of the time,3=Never",
    "ParentQuestion": "Q10"
  },
  {
    "Column": "Q10r3",
    "Description": "Q10r3: I used my phone/iPad to scan a QR Code and received the information on my device - Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of th",
    "Answer_Options": "1=All/most of the time,2=Some of the time,3=Never",
    "ParentQuestion": "Q10"
  },
  {
    "Column": "Q10r4",
    "Description": "Q10r4: The rep airdropped the information to my device - Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of the following approaches?",
    "Answer_Options": "1=All/most of the time,2=Some of the time,3=Never",
    "ParentQuestion": "Q10"
  },
  {
    "Column": "Q10r5",
    "Description": "Q10r5: The rep emailed the information to me, for me to review on my computer - Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of the followin",
    "Answer_Options": "1=All/most of the time,2=Some of the time,3=Never",
    "ParentQuestion": "Q10"
  },
  {
    "Column": "Q10r6",
    "Description": "Q10r6: The rep presented the information via a projector - Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of the following approaches?",
    "Answer_Options": "1=All/most of the time,2=Some of the time,3=Never",
    "ParentQuestion": "Q10"
  },
  {
    "Column": "noanswerQ10_r99",
    "Description": "noanswerQ10_r99: Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps share information with you, using each of the following approaches?: Check this box if you did not have any in-person",
    "Answer_Options": "0=NO TO: Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did yo,1=Thinking about your in-person meetings with pharmaceutical representatives in the past 6 months, how often did your reps",
    "ParentQuestion": "noanswerQ10_"
  },
  {
    "Column": "Q11r1",
    "Description": "Q11r1: The rep shows me print materials - Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the reps. Click to rank 1 for your most preferred",
    "Answer_Options": "NA",
    "ParentQuestion": "Q11"
  },
  {
    "Column": "Q11r2",
    "Description": "Q11r2: The rep shows me the information on his/her iPad - Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the reps. Click to rank 1 for you",
    "Answer_Options": "NA",
    "ParentQuestion": "Q11"
  },
  {
    "Column": "Q11r3",
    "Description": "Q11r3: I use my phone/iPad to scan a QR Code and receive the information on my device - Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the",
    "Answer_Options": "NA",
    "ParentQuestion": "Q11"
  },
  {
    "Column": "Q11r4",
    "Description": "Q11r4: The rep airdrops the information to my device - Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the reps. Click to rank 1 for your m",
    "Answer_Options": "NA",
    "ParentQuestion": "Q11"
  },
  {
    "Column": "Q11r5",
    "Description": "Q11r5: The rep emails the information to me, for me to review on my computer - Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the reps. Cl",
    "Answer_Options": "NA",
    "ParentQuestion": "Q11"
  },
  {
    "Column": "Q11r6",
    "Description": "Q11r6: The rep presents the information via a projector - Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the reps. Click to rank 1 for you",
    "Answer_Options": "NA",
    "ParentQuestion": "Q11"
  },
  {
    "Column": "noanswerQ11_r13",
    "Description": "noanswerQ11_r13: Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical representatives, during your in-person meetings with the reps. Click to rank 1 for your most preferred approach, 2 for second p",
    "Answer_Options": "0=NO TO: Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical re,1=Please rank order the following approaches, based on how you prefer to receive information from pharmaceutical represent",
    "ParentQuestion": "noanswerQ11_"
  },
  {
    "Column": "Q12",
    "Description": "Q12: Now thinking about the printed materials pharmaceutical reps leave behind for your use, which of the following best describes to what extent you used (i.e. opened, read, shared with a colleague or patient) these leave behind materials?",
    "Answer_Options": "1=I used all or most of these materials,2=I used a large proportion of these materials,3=I used a small proportion of these materials,4=I never or almost never used these materials,9=Reps did not leave behind any materials"
  },
  {
    "Column": "Q14",
    "Description": "Q14: To what extent are you interested in receiving unsolicited emails from pharmaceutical reps, that are not a follow up to your request or question?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested,99=Check this box if your level of interest depends on whether the email content is of your interest or addresses your need"
  },
  {
    "Column": "Q15r1",
    "Description": "Q15r1: Information customized for your and your patients’ needs - Which of the following topics would increase your likelihood to open an unsolicited email from pharmaceutical reps, that is not a follow up to your request or question?",
    "Answer_Options": "0=NO TO: Information customized for your and your patients’ needs,1=Information customized for your and your patients’ needs",
    "ParentQuestion": "Q15"
  },
  {
    "Column": "Q15r2",
    "Description": "Q15r2: New information relevant to the cancers you treat - Which of the following topics would increase your likelihood to open an unsolicited email from pharmaceutical reps, that is not a follow up to your request or question?",
    "Answer_Options": "0=NO TO: New information relevant to the cancers you treat,1=New information relevant to the cancers you treat",
    "ParentQuestion": "Q15"
  },
  {
    "Column": "Q15r3",
    "Description": "Q15r3: Information regarding coverage / reimbursement for the drugs $ {\"you\" if hS2.r1 else \"your practice\"} use - Which of the following topics would increase your likelihood to open an unsolicited email from pharmaceutical reps, that is not a follow up",
    "Answer_Options": "0=NO TO: Information regarding coverage / reimbursement for the drugs $ {\"you\" if hS2.r1 else \"your practice\"} use,1=Information regarding coverage / reimbursement for the drugs $ {\"you\" if hS2.r1 else \"your practice\"} use",
    "ParentQuestion": "Q15"
  },
  {
    "Column": "Q15r4",
    "Description": "Q15r4: Update about foundation support for the cancer drugs $ {\"you\" if hS2.r1 else \"your practice\"} use - Which of the following topics would increase your likelihood to open an unsolicited email from pharmaceutical reps, that is not a follow up to your",
    "Answer_Options": "0=NO TO: Update about foundation support for the cancer drugs $ {\"you\" if hS2.r1 else \"your practice\"} use,1=Update about foundation support for the cancer drugs $ {\"you\" if hS2.r1 else \"your practice\"} use",
    "ParentQuestion": "Q15"
  },
  {
    "Column": "Q15r5",
    "Description": "Q15r5: Information about financial support for your patients - Which of the following topics would increase your likelihood to open an unsolicited email from pharmaceutical reps, that is not a follow up to your request or question?",
    "Answer_Options": "0=NO TO: Information about financial support for your patients,1=Information about financial support for your patients",
    "ParentQuestion": "Q15"
  },
  {
    "Column": "Q15r6",
    "Description": "Q15r6: None of the above - Which of the following topics would increase your likelihood to open an unsolicited email from pharmaceutical reps, that is not a follow up to your request or question?",
    "Answer_Options": "0=NO TO: None of the above,1=None of the above",
    "ParentQuestion": "Q15"
  },
  {
    "Column": "S6a",
    "Description": "S6a: What percentage of your professional time is devoted to patient education?",
    "Answer_Options": "NA"
  },
  {
    "Column": "Q13r1",
    "Description": "Q13r1: Drug-related education (intended for HCPs) - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13"
  },
  {
    "Column": "Q13r2",
    "Description": "Q13r2: Education regarding the cancer (unbranded, intended for HCPs) - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13"
  },
  {
    "Column": "Q13r3",
    "Description": "Q13r3: General oncology education (intended for HCPs, not tumor specific, on topics such as precision medicine/biomarker testing, approaches to cancer treatment) - To what extent are you interested in receiving each of the following types of information (",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13"
  },
  {
    "Column": "Q13r4",
    "Description": "Q13r4: Branded patient education materials - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13"
  },
  {
    "Column": "Q13r5",
    "Description": "Q13r5: Unbranded patient education materials - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13"
  },
  {
    "Column": "Q13ar1",
    "Description": "Q13ar1: Business-Related, e.g. “Managing Work-Life Balance in an Oncology Clinic” - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13a"
  },
  {
    "Column": "Q13ar2",
    "Description": "Q13ar2: Inflation Reduction Act (IRA) Related, e.g. “How will new IRA policies impact your business” - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical co",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13a"
  },
  {
    "Column": "Q13ar3",
    "Description": "Q13ar3: Health Disparities & Equity, e.g. “Importance of Diversity in Clinical Trials” - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13a"
  },
  {
    "Column": "Q13ar4",
    "Description": "Q13ar4: Logistical Support, e.g. “Navigating Patient Volume with Limited Staff” - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical companies?",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13a"
  },
  {
    "Column": "Q13ar5",
    "Description": "Q13ar5: Unbranded Patient-friendly materials, e.g. “What to Expect After a Metastatic Diagnosis” - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical compan",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13a"
  },
  {
    "Column": "Q13ar6",
    "Description": "Q13ar6: Disease State Education, e.g. “Standards of Care in AML (or the cancer type relevant to you)\" - To what extent are you interested in receiving each of the following types of information (relevant to the types of cancers ) from pharmaceutical com",
    "Answer_Options": "1=1 - Not at all interested,2=2,3=3,4=4,5=5,6=6,7=7,8=8,9=9,10=10 - Extremely interested",
    "ParentQuestion": "Q13a"
  },
  {
    "Column": "Q16r8c1",
    "Description": "Q16r8c1: Commercial prescription coverage (employer-sponsored or self-insured) - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r9c1",
    "Description": "Q16r9c1: Medicaid (Medi-Cal for California residents) prescription coverage - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r10c1",
    "Description": "Q16r10c1: Medicare Part C / Medicare Advantage - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of your ability. The sum of your",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r11c1",
    "Description": "Q16r11c1: Medicare Part D without supplemental insurance - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of your ability. The s",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r12c1",
    "Description": "Q16r12c1: Medicare Part D with Supplemental (Medigap) prescription coverage - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r13c1",
    "Description": "Q16r13c1: Veterans Administration (VA), TRICARE, or military prescription coverage - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the b",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r14c1",
    "Description": "Q16r14c1: Other (please specify): - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of your ability. The sum of your answers must",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r15c1",
    "Description": "Q16r15c1: No prescription drug coverage - For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of your ability. The sum of your answer",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q16r14oe",
    "Description": "Q16r14oe: For oral oncology drugs specifically, what is the insurance distribution of your oncology patients at your primary practice setting/organization? Please estimate to the best of your ability. The sum of your answers must equal 100%. - Other (plea",
    "Answer_Options": "NA",
    "ParentQuestion": "Q16"
  },
  {
    "Column": "Q_End",
    "Description": "Q_End: You have completed the survey. Thank you for your time and participation! If you would be willing to participate in future research to further elaborate on the responses from this survey, please indicate below:",
    "Answer_Options": "1=Yes, I would be willing to participate in a follow-up interview for additional compensation,2=No, I am not interested in participating in a follow-up interview for additional compensation"
  },
  {
    "Column": "qtime",
    "Description": "qtime: Total Interview Time",
    "Answer_Options": "NA"
  },
  {
    "Column": "listAAID",
    "Description": "listAAID: Captured variable",
    "Answer_Options": "NA"
  },
  {
    "Column": "Source",
    "Description": "Source: on List Sample Data -Source",
    "Answer_Options": "NA"
  },
  {
    "Column": "Year_Qtr",
    "Description": "Year_Qtr: on List Sample Data -Year_Qtr",
    "Answer_Options": "NA"
  },
  {
    "Column": "NPI",
    "Description": "NPI: on List Sample Data -NPI",
    "Answer_Options": "NA"
  },
  {
    "Column": "First_Name",
    "Description": "First_Name: on List Sample Data -First_Name",
    "Answer_Options": "NA"
  },
  {
    "Column": "Last_Name",
    "Description": "Last_Name: on List Sample Data -Last_Name",
    "Answer_Options": "NA"
  },
  {
    "Column": "Astellas_Spec_Description",
    "Description": "Astellas_Spec_Description: on List Sample Data -Astellas_Spec_Description",
    "Answer_Options": "NA"
  },
  {
    "Column": "Astellas_Address_Line_1",
    "Description": "Astellas_Address_Line_1: on List Sample Data -Astellas_Address_Line_1",
    "Answer_Options": "NA"
  },
  {
    "Column": "Astellas_City",
    "Description": "Astellas_City: on List Sample Data -Astellas_City",
    "Answer_Options": "NA"
  },
  {
    "Column": "Astellas_State",
    "Description": "Astellas_State: on List Sample Data -Astellas_State",
    "Answer_Options": "NA"
  },
  {
    "Column": "Astellas_ZIP_Code",
    "Description": "Astellas_ZIP_Code: on List Sample Data -Astellas_ZIP_Code",
    "Answer_Options": "NA"
  },
  {
    "Column": "Address_P",
    "Description": "Address_P: on List Sample Data -Address_P",
    "Answer_Options": "NA"
  },
  {
    "Column": "City_P",
    "Description": "City_P: on List Sample Data -City_P",
    "Answer_Options": "NA"
  },
  {
    "Column": "State_P",
    "Description": "State_P: on List Sample Data -State_P",
    "Answer_Options": "NA"
  },
  {
    "Column": "Zip_Code_P",
    "Description": "Zip_Code_P: on List Sample Data -Zip_Code_P",
    "Answer_Options": "NA"
  }
]